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The Synthesis of Chiral Nucleoside Analogues
bv Peter Lloyd Armstrong BSc fHonsl
ABSTRACT
A basic introduction to a variety of nucleoside derivatives is described along with a selection of recent syntheses of the said compounds.Initial studies on the synthesis of the key furan based intermediate N-2,5-dihydro-5-(2,2-dimethyl-l,3- dioxolan-4-yl)furanyl trichloroacetamide which when hydrolysed to the free amine would yield a simple route to a variety of nucleoside derivatives. The synthesis was performed via the use of an aza-Claisen rearrangement on 1,4-anhydro-2-deoxy-5,6-o-isopropylidene-D-arabino- hex-l-enitol employing trichloroacetonitrile. This reaction proceeded to the desired amide in a facile manner, with excellent yield without the need for thermal rearrangement of the intermediate imidate. Initial efforts to hydrolyse this compound to the free amine proved inconclusive and this reaction was still being optimised at the close of the work.The Claisen rearrangement of l,4-anhydro-2-deoxy-5,6- o-isopropylidene-D-arabino-hex-l-enitol employing dimethylacetamide dimethylacetal proceeded successfully to produce an amide useful as an intermediate to the synthesis of furan C-nucleosides.The key carbocyclic allylic alcohol intermediate 5-methoxymethylcyclopent-2-enol was synthesized via a six step synthesis in racemic form from the ethylene-acetal of 2-methoxymethylcyclopentanone but attempts at deprotection of the methyl ether proved unsuccessful. Attempts to repeat this synthesis using protecting groups other than methyl ether failed at an early stage. The aza-Claisen rearrangement of this allylic alcohol with trichloroacetonitrile proceeded in good yield to cis-N- methoxymethylcyclopent-2-enyltrichloroacetamide. This amide was easily acid hydrolysed to the amine hydrochloride which was subsequently used to synthesize a variety of purine based nucleosides.5-Methoxymethylcyclopent-2-enol underwent the Claisen rearrangement with both dimethylacetamide dimethylacetal and triethylorthoacetate with the latters product showing promise as a useful intermediate to carbocylic C- nucleosides.
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CONVENTIONS
A hashed line m u  denotes an cc -configuration
A solid tapered line denotes a 5-configuration
A wavy line r W  denotes either an unknown or
unspecified configuration
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1. NUCLEOSIDES: AN INTRODUCTION
1.1 NUCLEOSIDES- Background of Medicinal Uses
For a number of years it has been well established 
that nucleosides and their analogues show activity 
against a variety of physiological ailments. The main 
areas in which they have been of greatest use are as 
anti-cancer and antiviral agents.
Viral infections account for about 60 percent of all 
illnesses in developed countries. This is in contrast to 
the 15 percent attributable to bacterial infections.
There are obviously many varieties of virus which include 
Herpes simplex virus (HSV) types 1 and 2, the cause of 
'cold sores', encephalitis and eye and genital infections 
and Varicella zoster virus (VZV), the cause of chicken 
pox and shingles. Epstein-Barr virus (EBV) causes 
mononucleosis which is better known as glandular fever.
To combat this variety of viral infections, numerous 
classes of compound have been tested of which nucleosides 
and their analogues have been found to be particularly 
useful as agents against a wide spectrum of disorders.
An example of a particularly interesting nucleoside 
analogue is acyclovir (1) which is an effective and 
selective inhibitor of HSV replication with very low 
toxicity against host a n i m a l s ^ I t  is manufactured by
-6-
the Wellcome Foundation and is now also used in 
conjunction with AZT for the treatment of Acquired Immune
Deficiency Syndrome (AIDS).
. . . (2 ) .Cyclocytidine hydrochloride (2)v ' is effective in
the treatment of leukemia L1210 and is also a wide 
spectrum antiviral. 5-Fluorouridine (5-FU) (3) is at 
present used in the treatment of solid tumours’ such as 
gastrointestinal and breast tumours' 1 and 2'-fluoro-5- 
iodo-aracytosine (FIAC) (4) is highly active against 
various strains of HSV 1 and 2' '. FIAC is in fact 
slightly more active against HSV 1 than acyclovir but it 
is slightly more toxic to the normal cells. A compound 
which shows strikingly strong inhibitory effects on 
influenza and parainfluenza virus replication which has 
been licensed for use in humans in a variety of countries 
is ribavarin (5) (5'6).
+ _
H2, x x ;
h o h 2c h 2c-°n !
(1)
NH2C1
HO,
HO
HN
HO,
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(2 ) (3)
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Research into the use of nucleosides as 
pharmaceuticals has however taken off in recent years 
after it was discovered that some are potent inhibitors 
of Human Immunodeficency Virus (HIV). It is this virus 
which, it is thought, produces the fatal disorder of 
AIDS. The following account explains in more depth the 
use of nucleosides as antiviral agents, taking HIV as the 
example virus. Throughout the text reference will be 
made to antiviral activity and this will imply anti-HIV 
activity; however, many of the compounds also show a wide 
spectrum of antiviral activity.
1.2 INTRODUCTION TO HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Research into novel antiviral compounds has become 
one of the biggest growth areas in science in recent 
years and this is due, mainly, to the spread of the fatal
-8-
disease Acquired Immune Deficiency Syndrome (AIDS).
Within the scientific community there is still some 
speculation as to the exact causes of the syndrome, but, 
the consensus of opinion lies with one theory. It is 
thought that a retrovirus^7'8  ^ replicates within the 
immune system of the host leading to the destruction of
T4+ cells. It is this drastic reduction in the host's
+ f 9 ^ .T4 cell count which is the cause of AIDS' '. This
retrovirus is the third such virus to be detected which
affects the human population and as such has been termed
Human T-Lymphotropic Virus 3 (HTLV-3) but this is now
better recognised by its more recent name of Human
Immunodeficiency Virus (HIV)
The retrovirus HIV once within a host's body infects 
in a roost subtle way. The virus first recognises a 
receptor site on the T4+ cell and binds to it. Next by a 
fusion process the virus deposits its contents consisting 
of a strand of viral RNA (vRNA) and the ingenious enzyme 
viral reverse transcriptase within the host cell. Within 
the T4+ cell the vRT uses vRNA from HIV as a template to 
form a strand of viral DNA (vDNA). A double strand of 
vDNA is then generated and this inserts itself into the 
T4+ cell's chromosomes. No effect on the host cell is 
noticed until cell replication occurs. With the vDNA 
inserted into the parent cell, the new cell replicants 
produced are genetically altered and can now no longer
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perform their assigned immune system function. The human 
host therefore, slowly loses its ability to combat 
disease due to the depletion of functioning T4+ cells.
At this point viral and bacterial ailments which, to a 
healthy human, are easily combated now become life 
threatening without the use of drugs and so common 
disorders such as influenza are thus often fatal to a 
patient with AIDS. It has also been shown that HIV 
infection leads to dementia and loss of intellectual 
functioning of the host.
The life cycle of HIV would appear to allow various 
areas at which to disrupt it and so arrest its fatal 
effects^1 0 As the virus binds to the target cell 
antibodies to the virus or cell receptor could be 
employed. The viral RNA must be transcripted to a strand 
of DNA by the enzyme reverse transcriptase and so 
inhibitors to this enzyme would disrupt the life cycle of 
HIV. The virus also goes through a budding stage and it 
is known from other viruses that interferons can help 
prevent this stage from occurring. Other areas of the 
life cycle of HIV which appear to show opportunities at 
which to disrupt it include the integration of DNA into 
the host genome, expression of the viral genes and the 
degradation of viral RNA in the RNA-DNA hybrid.
-10-
Possibly the most obvious link which could be disturbed 
by chemical means is the use by HIV of the vDNA producing 
enzyme vRT. vRT is unique to HIV and is not found 
naturally within the human body and therefore, if an 
inhibitor which was totally selective for vRT could be 
found it would in no way effect the normal bodily 
functions of the human host. A large majority of the 
work in the medicinal chemistry field has therefore been 
concentrated in the production of vRT inhibitors.
Obviously within the human body there are many 
thousands of vitally important enzymes all of which, 
along with vRT, are merely complex protein strands. The 
greatest therapeutic difficulty encountered for the 
medicinal chemist is to produce a drug which inhibits vRT 
but also does not interfere with those closely related, 
important, natural human enzymes. Any reaction of the 
drug with these human enzymes could lead to side effects 
which might be pernicious. One vital enzyme often 
affected by these vRT inhibitors is DNA polymerase alpha 
and this manifests itself as the side effects of 
leukopenia and anaemia. The therapeutic and hence 
synthetic aim is therefore to produce inhibitors which 
are highly selective for vRT leaving the patient free 
from any harmful side effects.
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1.3 vRT INHIBITORS; Structure and Mode of Action
In order to inhibit vRT, compounds must be found 
which either block the active site of the enzyme to vRNA, 
or affect the sequencing of the vDNA chain by direct or 
indirect means. The usual substrate for vRT is vRNA, 
which is a long chain nucleotide with the general 
structure shown (Figure 1).
Figure.1
An obvious choice as an inhibitor might therefore 
appear to be a simple nucleoside as this has the correct 
structure to enter and block the active site of vRT to 
the approach of its true substrate vRNA. One such 
compound might be thought to be the naturally occurring 
nucleoside 2'-deoxyadenosine (6). As the name implies 
however, 2'-deoxyadenosine is a member of the 
deoxynucleoside family of compounds, the normal building 
blocks of DNA. Hence the vRT is able to utilize it in
0
0 = P  OH
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the construction of its own vDNA chain and no vRT 
inhibition is seen.
NH
HO.
(6)
Simple changes in chemical functionality at certain 
carbons around the sugar ring can however infer inhibitor 
qualities and the main change found to be effective was 
to have carbons 2 and 3 (C2' and C3') free from hydroxyl 
(OH) groups. The hydroxyl groups on the sugar ring at 
these positions form phosphate bonds which link one 
nucleotide to another in a DNA chain. In analogues 
without hydroxyls at C2' and C3' this link is unable to 
be formed and DNA chain growth is terminated. This gives 
us the class of compounds known as 2',3/- 
dideoxynucleosides and these have been found to be potent 
inhibitors of vRT 'in vitro'. Following this argument it 
might be thought that removal of the hydroxyl at C5' 
would also infer inhibition of vRT however, removal or 
replacement of the C5' hydroxyl leads to a complete loss 
of activity. This is because the C5' is now no longer
-13-
available for phosphorylation and this stage is very 
important, being performed by the host cells own kinase 
enzymes. Nucleosides in their C5' unphosphorylated form 
are not active and it is impossible to administer the 
drug in the phosphorylated form as it cannot be absorbed 
by the bodily cells. Therefore, the C5f hydroxyl must be 
present to allow kinases to phosphorylate the absorbed 
drug into its active state which can then inhibit vRT.
This inhibition can be by two main means, competitive 
inhibition and chain termination. In competitive 
inhibition the drug triphosphate binds to the vRT active 
site, in preference to vRNA. Due to the lack of 
hydroxyls at C2' or C3' the enzyme cannot use it as a 
substrate to initiate chain growth and thus production of 
vDNA is arrested. For chain termination to occur the 
drug triphosphate must first be incorporated into the 
growing vDNA chain. When the vRT attempts the next link, 
from the inhibitor nucleoside, it cannot due to the lack 
of the necessary hydroxyl at C2' or C3'. The growing 
vDNA chain is thus terminated and the life cycle of HIV 
is blocked. It is usual that compounds which inhibit vRT 
exhibit both competitive inhibition and chain termination 
as their modes of action.
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1.4 NUCLEOSIDES
1.4.1 Classical Syntheses
The term "nucleoside” initially was a reference to 
the pyrimidine and purine N-glycosides derived from 
nucleic acids. The common structural characteristic of 
all these compounds is the presence of a carbohydrate 
group, usually 2-B-deoxy-D-ribofuranose or B-D- 
ribofuranose, linked to a heterocyclic base.
The first nucleoside to be synthesized in the
laboratory was 7-B-D-glucopyranosyltheophylline by
Fischer and Helferich when they condensed tetra-o-acetyl-
c?C -D-glucopyranosyl bromide with the silver salt of
theophylline in refluxing xylene^11'12^. The first
synthesis of a more important nucleoside, adenosine (7),
(13)was by Todd and his co-workersv ' using the methodology 
of Fischer and Helferich. The silver salt (8) reacts 
with the ribose derivative (9) in refluxing xylene and 
reduction, followed by reaction with ammonia yields 
adenosine (7). Two improvements over this silver salt 
technique were introduced by Davoll and Lowy^14  ^ who 
firstly reduced the basicity of the purine by acylation 
of the amino group and secondly made use of a 
chloromercury salt instead of the silver salt. Such a 
purine is shown (10).
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AcO
AcO OAc
Cl
Cl
AcO.
AcO OAc
(ii)
HO,
HO OH
(7)
Reagents: (i) xylene/ reflux, (ii) a) reduction,
b) NH3/ EtOH
NHCOC6H5
's
(10)
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The silver salt mechanism of Fischer is also 
applicable to the pyrimidine nucleoside analogues.
Mercury salts of pyrimidines have also been successfully 
used in a number of cases but both of these methods had 
obvious drawbacks synthetically. The silver salt 
technique was expensive and the use of highly toxic 
mercury made both routes poor for larger scale syntheses 
and so other more viable routes were therefore obviously 
required.
Hilbert and Johnson discovered a method of 
synthesizing pyrimidine nucleosides by the reaction of a 
dialkoxypyrimidine (11) with an alkyl halide (RX) which 
affords 4-alkoxy-N'-alkyl-2-pyrimidones (12). These 
products can then be easily reacted to give either uracil 
or cytosine nucleosides as shown (Scheme 1). The same 
methodology using a poly-o-acylsugar halide as the alkyl 
halide component is referred to as the classical Hilbert- 
Johnson synthesis of N-glycosidesv ' and this became the 
first general method for the preparation of pyrimidine 
nucleosides.
The next major advancement in nucleoside synthesis 
came with the developments in organosilicon chemistry. 
Birkofer et al^16  ^ used trimethylsilylated (TMS) bases in 
preference to the older dialkoxy derivatives (Scheme 2).
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Scheme 1
OEt OEt
N*' >  N1
EtO A, *  o A
(11)
IR
(12)
(iii)
n h 2
N
IR
(Uracil) (Cytosine)
Reagents: (i) RX, (ii) HCl/EtOH, (iii) NH3/EtOH
OTMS
Scheme 2
TMSO
OTMS
Cl+
BzO OBz
BzO.
BzO OBz
uridine/cytidine
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This type of methodology is now the typical synthetic 
route to both purine and pyrimidine nucleosides and the 
synthesis has been further advanced by the use of various 
conditions and reagents such as the use of
(17 18}hexamethyldisilazane and trimethylsilytriflate' 9 '.
(Figure 2)
Figure 2
ArO.
>Ac
OAc 0
(i)
ArO.
OAc
Reagents .... XXH f Me3SiCl,hexamethyldisilazane, Me3Si0S02CF3, 60 , 2 hours
1.4.2 Compounds of Current Interest
As has already been stated the main interest at
present is in the class of compounds known as 2',3'-
(19}dideoxynucleosides' 9 many of which have shown promising 
anti-retroviral activity 'in vitro' . Of these compounds 
the market leader for AIDS treatment is 3'-azido-3'- 
deoxythymidine (13).
-19-
0
HN
HO.
n 3
(13)
It is manufactured by the Wellcome Foundation Limited and 
is better known as either AZT, zidovudine or its UK brand 
name Retrovir. AZT was synthesized over 20 years ago by
Horwitz et al^20  ^ employing the classical Hilbert-Johnson
. fi5V .nucleoside synthesisv ' to produce the thymidine
derivative which could then be reacted to yield AZT (13)
(Scheme 3).
It was not until ten years later that Ostertag et
( 21 )alv ' discovered that AZT was indeed an active
(2 2 )antiretroviral but due to its toxicityv ' no useful 
medical application was apparent. With the advent of 
HIV/AIDS, AZT was re-evaluated and it exhibited vigorous 
inhibition of HTLV-3 replication 'in vitro'*
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Scheme 3
“N H
Tr
OH
\\
NH
HO,
(i) — ►
TrO
/
CH3SO2h
V1
TrO
(iii)
v -
n 3
(AZT) (13)
Reagents: (i) methanesulfonyl chloride/ 0 / 1 6  hr/
pyridine, (ii) LiN3/ 3hrs/ 100°/ H2/ DHF, (iii) CHC1. 
HC1/ 0°/ 1 hr
More recent methods of AZT synthesis still stem from
thymidine starting materials and one such route is to
first produce a 2',3'-anhydro thymidine derivative using
. . (23)a one-pot reaction from thymidinev 1 (Scheme 4). The 
isolated product is then treated with lithium
-21-
azide^24'25  ^ under nitrogen with heating, subsequent 
deprotection of the benzoate ester yields the required 
product AZT.
Scheme 4 n
HO.
OH
(ii)
▼
0
n 3
(AZT) (13)
Reagents: (i) a) DIAD/ PPh3/ benzoic acid/ 22°/ DMF
b) PPh3/ DIAD, (ii) LiN3/ DMF
The mode of action of AZT^10  ^ is similar to that of 
other 2', 3'-dideoxynucleosides in that it acts as both 
competitive inhibitor and a chain terminator. However, 
AZT has signifiant advantages over other drugs in its
class. As has been previously stated, HIV affects the 
brain and central nervous system leading to types of 
dementia and AZT is the only antiretroviral compound 
known at present which can enter the brain and help 
prevent this neurological damage caused by HIV. The 
drawbacks of AZT are that it is highly toxic 
(particularly to bone marrow) and is quickly metabolised 
or excreted by the body and a further problem which has 
surfaced more recently is the emergence of AZT resistant 
strains of HIV.
With this resistance problem at hand other 2',3'- 
dideoxynucleosides have been synthesised and one compound 
of great interest is 2',3'-dideoxyinosine (ddl)
This compound has been found to be an antiretroviral 
'in vivo' and has recently been ratified as a prescribed 
drug for the treatment of AIDS in the USA. At present it 
is only available to patients who either did not respond
0
(14)
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to or who were unable to use AZT.
Other compounds with the 2',3'-carbon positions 
saturated with hydrogen have also shown promising results 
of which two compounds of particular interest are 2',3'- 
dideoxycytosine (ddC)^18  ^ (15) and 3'-deoxy-2',3'- 
didehydrothymidine (d4T)^17  ^ (16).
HO.
(15)
HO,
(16)
Other series of compounds which have shown promising
initial biological results have been the modified
( 42 )analogues of AZT and d4T, fluorothymidmev * (FLT) (17)
. . fl7^and 2' -deoxy-2', 3' -didehydro-3' -methylthymidmev J (18). 
FLT is equipotent 'in vitro' but 10 times more effective 
'in vivo' than AZT. This has been shown experimentally
using the monkey infected with SIV as a model. A
particularly interesting aspect of (18) was the 
unsaturation at C2' and C3' as this is a modification 
which has led to a series of compounds with 
antiretroviral activity.
-24-
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HO,
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All the 2',3'—dideoxynucleosides do however have a 
common drawback which has led to the search for new 
classes of antiretrovirals. This is that being so 
closely related, structurally, to the normal building 
blocks of RNA/DNA they are prone to destruction by the 
human bodily enzymes. These enzymes attack the link 
between Cl' of the pentacyclic sugar ring and the 
nitrogen of the attached heterocyclic base (i.e{ the 
-O-C-N- linkage). Therefore the new classes of 
antivirals, although retaining an overall nucleoside type 
skeleton must dispense with this -O-C-N- glycosidic link, 
which is so easily disrupted.
-25-
1.5 C—NUCLEOSIDES
This class of antivirals have the apparent advantage 
over normal nucleosides in that they do not contain the 
enzymatically degradable -O-C-N- linkage. They are in 
the form shown (Figure 3) with the sugar Cl' being bonded 
to a carbon in the heterocyclic base as opposed to a 
nitrogen.
Figure 3
Base
RO
As can be seen there is now an -o-C-C- series of bonds 
rather than -O-C-N- glycosidic link and this new 
arrangement is far more stable to enzymatic degradation. 
Consequently this category of nucleoside, it was hoped, 
could be more potent antivirals than the 2',3'- 
dideoxynucleoside analogues.
The first naturally occurring C-nucleoside to be 
identified was 5-B-D-ribofuranosyluracil (pseudouridine) 
(19) which is an important fragment of tRNA.
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0HO
HO OH
(19)
A number of interesting C-nucleosides have since been
isolated and synthesized in the laboratory of which two
of the most important have been formycin (20) and
showdomycin (21). Formycin was first isolated in the
Institute of Microbial Chemistry, Tokyo from Nocardia
interforma during a screening for antitumour activity' '
in 1964 and has both significant antiviral and antitumour
activity. The first of these formycins to be synthesized
in the laboratory was the analogue oxoformycin (22) by
(27)Farkas and Sormv * .
n h 2 o
HO OH HO OH HO OH
(20) (21) (22)
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Since this synthesis many analogues have been developed 
and much work has been perfomed in this area by Buchanan 
et al(28>.
Probably the largest volume of work in the C-
nucleoside field has been on the compound
f 29 30 ^showdomycin^ ' ' which was initially discovered by a
research group at the Shionogi Research Laboratory led by
( 31)Nishimura1 ; m  1964 by isolation from Streptomyces 
showdoensis. Showdomycin exhibited antiviral activity 
'in vitro' and is also active against gram-positive and 
gram-negative bacteria and tumours. The synthesis of the 
compound has usually been tackled by one of two routes. 
Either D-ribose is used, which leads to optically active 
showdomycin, or furan is employed to derive the ribose 
unit by cycloaddition followed by stereoselective 
hydroxylation.
The area of using C-nucleosides for the treatment of 
HIV is of interest due to the stability of the -0-C-C- 
series of bonds. However, as yet no compound in this 
class has been discovered which shows any significantly 
useful anti-HIV activity. Due to this fact, the majority 
of work in the anti-HIV field has continued in the areas 
of nucleoside analogues and the newer carbocyclic 
nucleosides.
-28-
1.6 CARBOCYCLIC NUCLEOSIDES
1.6.1 Background and Synthesis
Both nucleosides and C-nucleosides are found 
occurring naturally in the human body with the advantage 
of the C-nucleosides being their stability to bodily 
enzymes. Unfortunately, as yet, no potent anti-HIV 
compound has been discovered in the latter class of 
molecules. With the drawbacks in these two fields 
scientists took the next obvious step towards a new 
series of compounds and this step was to alter the 
nucleoside framework by replacing the oxygen atom of the 
furan sugar ring with a methylene group so producing a 
cyclopentane analogue. It was hoped that this step would 
maintain the stability towards enzymes shown by C- 
nucleosides yet keep the high activity of the 
nucleosides.
The early inventive work in this field was attempted
r 30 \by Shealy and Claytonv ' who initially synthesized 
racemic carbocyclic analogues of the adenosine, inosine, 
6-mercaptopurine and 6-(methylthio)purine nucleosides. 
Their first synthesis was that of carbocyclic adenosine
(23).
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HO
HO OH (23)
Biological studies showed (23) to be highly cytotoxic and 
that it was a substrate for both kinase and deaminase 
enzymes. Shealy's synthesis used norbornadiene as the 
starting material which by a 4 step process (scheme 5) 
produced 2 oL ,3 cL -diacetoxy,IB,4B- 
cyclopentanedicarboxylic acid anhydride (24).
Scheme 5
(i) (ii)
HO OH AcO OAc
(iii)
(24) (iv)
AcO OAc AcO OAc
Reagents: (i) KMnO^/ -70°, (ii) acetic anhydride/ -70°
to 22°, (iii) NaMnO^/ C02 , (iv) ethoxyacetylene
-30-
Ring opening of the acid anhydride to yield the acid- 
amide functionality was followed by 5 further steps which 
ultimately led to the key intermediate (25) (±)-45- 
amino ,2 ot ,3 ol-dihydroxy-lB-cyclopentanemethanol (scheme 
6).
Scheme 6
xOsOC CO
AcO OAc
HO. NHAC
HO OH
(i)
(v)
h o 2c c o n h2 (ii) H02C n h 2
AcO OAc AcO OAc
(iii)
c h 3o2c NHAC (iv) CH302C n h 2
AcO OAc nAcO OAC
(vi)
V
HO.
HO OH
Reagents: (i) NH3 (g)/ 5°, (ii) Br2/ HaOH, (iii)CH3OH
HC1 (g), (iv) acetic anhydride/ pyridine, (v) LiBH./ 40 
(vi) a) carbon/ HC1, b) NH3
From the key amine intermediate (25), well published 
methods for the synthesis of the base moiety were 
applicable. To furnish carbocyclic adenosine Shealy 
reacted the amine (25) with 5-amino-4,6- 
dichloropyrimidine which followed by ring closing with 
triethyl orthoformate and amination in liquid ammonia 
gave the compound (26) (scheme 7).
Scheme 7
Cl
h 2n .
HO,
HO OH
HO, n h 2
HO OH
(ii)
NH2
N.<NHO
HO OH
(iii)
Cl
N
NHO.
HO OH
(26)
Regents: (i) 5-amino-4,6-dichloropyrimidine/ butanol/
Et3N, (ii) HC(OEt)3/ H+ , (iii) NH3
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These early routes were too lengthy to allow rapid
analogue preparation and the next step forward was made
( 33 ^by Daluge and Vince' ' by their use of the compound 2- 
azabicyclo[2.2.1]hept-5-ene-3-one (27). Here they 
reported the synthesis of carbocyclic arabinosyladenine 
which showed promising antiviral and antitumour activity. 
Kam et al^34  ^ furthered this work utilising (27) to 
produce a series of amine intermediates which were 
extremely useful for carbocyclic nucleoside synthesis.
NH
(27)
This lactam (27) has since become the basic starting 
material for a large volume of work in this field as it 
is readily available in chiral form and therefore gives 
an easy introduction to the synthesis of chirally pure 
carbocyclic nucleosides.
1.6.2 Compounds of Current Interest
One initially very interesting compound was
neplanocin-A (28). The neplanocins were first isolated
(35^from a cell culture m  1979v ' and neplanocm-A 
demonstrated superior antitumour activity^36^. The first
-33-
total synthesis of this compound in chiral form was by a
( 37 )group at the University of Tokyo' ' followed a few
( 38 )months later by Marquez' ' who employed a vastly 
different method.
HO.
HO OH
(28)
A vigorous worker in this field of carbocyclic
(39—41^nucleosides has been Roberts' . He has produced
many elegant papers dealing with carbocyclic syntheses 
and recently his group have produced some interesting
(A2)carbocyclic AZT analogues' ' which have shown anti-HIV 
activity. Probably the most useful compound dealt with 
by Roberts has however been carbovir (29) which has 
recently been put forward as a possible chemotherapeutic 
agent for the treatment of patients infected by HIV.
0
HO
(29)
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Roberts and his co-workers have synthesized chirally
which the first employed a linear approach starting from 
the chirally pure (-)-lactam (27). Ring opening of the 
lactam was followed by protection of the acid and amine 
to generate (30) (scheme 8). Reduction of the ester and 
hydrolysis of the amide allowed reaction with 2-amino- 
4,6-dichloropyrimidine and four further well known 
reactions led to the final product; (-)-carbovir (29).
Scheme 8
(43 }pure carbovir by two distinctly different routes' ' of
0
>
(30)
(Carbovir)
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The second method employed a convergent approach 
where reaction of cyclopentadiene with formaldehyde and 
formic acid followed by treatment with base gave a 
mixture of (±)-4-cis-hydroxycyclopent-2-enylmethanol 
isomers (31). Protection of the primary alcohol as the 
trityl ether and subsequent enzymatic acetylation of the 
secondary alcohol with Pseudomonas fluorescens lipase as 
catalyst furnished the optically pure ester. Reaction of 
this ester with 2-amino-6-chloropyrimidine, sodium 
hydride and palladium tetrakis(triphenylphosphine) and 
subsequent hydrolysis with base produced the optically 
active (+)-carbovir (32) (scheme 9).
Scheme 9
(31)
Within the last few years some extremely novel 
carbocyclic mimics of nucleosides have been developed and 
the following examples have replaced the cyclopentane 
ring with a variety of groups. In penciclovir (33) a 
branched alkyl chain is used and this compound is highly 
active against herpes simplex virus types 1 and 2. The 
isomeric compound (34)^44  ^ has also been shown to exhibit 
potent antiviral activity, where a cyclobutyl ring has 
replaced the original cyclopentyl.
NH
HO,
(33)
OH
(34)
(45) (46)Both Norbeck et alv'“'' and Green et al' ' have replaced 
the cyclopentane with a cyclopropyl ring but as yet none 
of these compounds has shown any marked antiviral 
activity.
1.6.3 Carbocyclic C-Nucleosides
This area has not been particularly well investigated 
in comparison with the other classes of compounds already 
mentioned and this is probably in the main due to the
-37-
decreased activity of C-nucleosides as compared with
nucleosides. However, if a compound existed which was
active in this class it would have the excellent property
f47)of being highly stable to enzymatic attack. Saksenav ' 
has described a route to carbocyclic C-nucleosides but as 
yet none of the products synthesized have shown 
interesting antiviral activity.
1.7 INITIAL AIMS OF THE RESEARCH PROJECT
In simple terms the purpose of the project was to 
develop new routes to the four classes of nucleoside 
analogues already mentioned (nucleosides, C-nucleosides, 
carbocyclic nucleosides and carbocyclic C-nucleosides) 
ultimately in chiral form. These routes would involve 
the use of either an intramolecular Claisen or aza- 
Claisen rearrangement to establish the correct general 
stereochemistry. It was hoped that any nucleoside 
analogues synthesized would be submitted for biological 
testing by the collaborating body, the Wellcome 
Foundation Limited.
Routes to 29,3 9-dideoxynucleosides
The fundamental reaction was to be an aza-Claisen 
rearrangement^48  ^ on the glycal (35) which was readily
-38-
available via a three step synthesis. The 
trichloroacetamide could then be hydrolysed to the free 
amine as shown in scheme 10 and the desired heterocyclic 
base could subsequently be formed by well published 
methods using the amine as a *synthetic handle'.
Scheme 10
0.
0‘
OH
(35)
(i) X
u
NHC(O)CC13
(ii)
Base0
0 O XD0
Reagents: (i) a) C13CCN/ O , b) Hg(OCOCF3)2
(ii) NaOH/ EtOH
Route to C-Nucleosides
Again the glycal (35) was to be used as the 
precursor. The glycal was to be reacted in a Claisen 
rearrangement as described by Ireland et al^49  ^ and shown 
in figure 4.
-39-
Figure 4
(i)
OH
(35)
Reagents: (i) a) XCYHCOC1, b) LDA, c) Me^iCl, d) heat
Variation of X and Y to SPh or OMe could provide a useful 
'synthetic handle' upon which to build the required 
heterocyclic base.
Route to Carbocyclic and Carbocyclic C-Nucleosides
Analogous Claisen and aza-Claisen rearrangements to 
those shown in scheme 10 and figure 4 could be employed 
in the carbocyclic series. Firstly however the 
cyclopentane allylic alcohol (36) required for these 
rearrangements would have to be prepared and this was to 
be achieved using a modified method previously outlined 
by Paulsen and MaaB^50  ^ (Figure 5).
P;Lgure_5
O
HO (36)
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This route leads to the required cyclopentane allylic 
alcohol as a racemate but the desired chiral form could 
be isolated via a variety of techniques.
Three techniques are widely used both in industry and 
academia. The classical method and one which is 
particularly useful when dealing with large scale 
reactions is a resolution in which the reaction of the 
racemate with an optically pure carboxylic acid. This 
would produce a pair of diastereomeric esters which could 
then be separated by physical techniques such as 
chromatography or recrystallization.
The second method could be to employ an enzymatic 
resolution somewhere in the synthesis. This technique 
employs an enzyme which will effect a reaction on only 
one of the enantiomers of the compound being used. A 
good example of this is the use by Roberts^43  ^ of 
'Pseudomonas fluorescens' lipase with vinyl acetate to 
react with the racemic alcohol (37) (Figure 6). Only the 
(+)-form of the starting alcohol is reacted on by the 
enzyme to yield an acetate (38) which can then be 
isolated by physical methods, thus procuring the molecule 
in chiral form. It would certainly appear possible to 
use this methodology to isolate chirally pure material 
from the allylic alcohols (36).
The third method would be to employ one of the new
-41-
range of chiral reducing agents for reducing a ketone 
such as R- or S-Alpine hydride, which are borane 
derivatives. Chiral reducing agents react with a pro- 
chiral material generating an excess of one of the 
optically active forms. A distinct advantage of this 
method is that unlike the previous two methods, where 50% 
of the starting material is wasted, a majority is 
employed in preferentially producing one chiral form.
Figure 6
.OCPh
(37) (+) (38) (-)
-42-
CHAPTER 2
FURAN BASED NUCLEOSIDES AND C-NUCLEOSIDES
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2. FURAN BASED NUCLEOSIDES AND C-NUCLEOSIDES
2.1 BACKGROUND- Synthesis
As has been previously stated the above classes of 
compound are of great interest for use as 
pharmaceuticals, mainly in the fields of antiviral and 
anticancer medicine. From naturally occurring furan 
nucleosides it has been possible to synthesize a variety 
of novel analogues which have shown enhanced medicinal 
activity, some of which have been mentioned earlier in 
this text such as AZT (13), FLT (17) and ddl (14). The 
recent rapid development of nucleosides as pharmaceutical 
agents has arisen due to their selective inhibition of 
viral enzymes and they have shown activity against a 
variety of viral infections such as HIV, VZV and HSV 
types 1 and 2.
The classical synthesis of nucleosides has already 
been outlined earlier in chapter 1. There are two 
distinct methods of synthesis, namely a convergent 
approach or a linear route.
In the field of nucleoside synthesis the linear 
approach has been mainly used in routes to C-nucleosides. 
A linear synthesis is one in which the entire target 
molecule is built up in consecutive small steps and has
-45-
the main disadvantage of producing relatively poor 
overall yields of a target molecule over a long multi- 
step synthesis. However, for the production of C- 
nucleosides this has proven to be the main method of 
synthesis. This linear approach is shown well by Poonian 
and Nowoswiat^51  ^ (Scheme 11) in their synthesis of the
C-nucleoside analogues of the immunosuppressive and
. . . (52)antiviral agent brednmv ' (39).
Scheme 11
BzO, CN
BzO OBz
(i)
NH
HO, C OCH3
HO OH
r
HO'r-rN ^ N H^ conh2
HO.
HO OH 
(39)
(iii)
NH.HC1 ,CONH2
HO C— NH— CH
HO OH
Reagents: (i) NaOCH3, (ii) (NH2CO)2CHNH2.HC1/ DMSO
(iii) H20/ heat
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This scheme shows very well a linear synthesis with the 
heterocycle being built onto the sugar moiety in a three 
step process.
For the production of nucleosides, mainly the 
convergent approach is utilised as it has the advantage 
that yields of the target molecule are significantly 
higher than for a comparative linear synthesis. The 
classical syntheses of nucleosides discussed previously 
employ this convergent methodology where the final 
molecule is built up by reacting together large, 
previously synthesized portions of the target compound. 
This method can be seen in the synthesis of ddC and CNT 
by Okabe et al^18\
5
‘OTMS
Reagents: (i) Lewis acid, CH2C12, (ii) a) H+ b) HO
ddC <
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As can be seen the two main portions of the 
nucleoside, the sugar and base, are reacted together in 
one step to produce (40) in a typical convergent 
synthesis.
The initial aims of the research project were to 
employ Claisen and aza-Claisen rearrangements on a 
suitable allylic alcohol. These reactions would lead to 
compounds containing synthetic 'handles' with the correct 
relative stereochemistry for heterocyclic base synthesis. 
Therefore, it was initially envisaged that a linear 
approach would be used for the overall synthesis of the 
nucleoside analogues but for this approach to be 
applicable a suitable allylic alcohol had first to be 
found. Once synthesized the allylic alcohol would have 
the desired rearrangements performed on it.
2.2 SYNTHESIS OF THE FURAN ALLYLIC ALCOHOL (35)
The furan allylic alcohol (35) derived from D-mannose 
appeared to be ideal for the purposes of the project as, 
being derived from a sugar, it was chiral and it also 
contained an interesting isopropylidene protecting group. 
As can be seen from previous examples the majority of 
nucleoside analogues contain a simple single primary 
alcohol at the C5' position. The isopropylidene group in
-48-
the mannose derived compounds could be deprotected to 
generate the diol and from this functionality numerous 
reactions could be performed preferentially on either the 
primary or secondary alcohols to instil novelty into any 
final nucleoside analogues synthesized.
0
0
OH
(35)
This compound (35) was synthesized by a three step 
procedure from D-mannose (Scheme 12). Refluxing D- 
mannose with concentrated HC1 m  acetonev ' furnished,
after recrystallization, the alcohol (41) in excellent
lyield (85%). H NMR confirmed the product as the desired 
ring closed hemi-acetal (41). Particularly indicative 
was the singlet and doublet witnessed at 1.36-1.46 delta 
which correlated for the 12 hydrogens of the two 
isopropylidene protecting groups. The alcohol was then
chlorinated in CCl^ containing a molar equivalent of
( 53 1Ph3P v ' and this reaction produced the glycosyl chloride 
in good yield as an orange liquid (70.4%). Complete 
disappearance of the starting material was established by 
the lack of any OH stretching frequency in the IR 
spectrum of the crude product. It should be noted that 
the yield of this reaction was very dependent upon the
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quality of the solvent employed. Use of CC14 which had
not been dried thoroughly led to significant drops in
yield and so before each new reaction was commenced the
required amount of CCl^ was freshly distilled into the
reaction vessel. Difficulties were also encountered
during the work up of this reaction as following
filtration and concentration under reduced pressure a
thick, sticky mixture of product and Ph3P=0 was left.
Isolation of the product from this mixture proved very
difficult. The solution to this problem was to perform a
series of semi-concentrations and subsequent filtrations
of the precipitated Ph3P=0 thus leading to the production
of a reasonably pure sample of glycosyl chloride.
Although H NMR still showed the presence of Ph3P=0
(<10%) this proved to have no effect on the next stage of
the reaction scheme and so was ignored. The third and
final stage in the synthesis was a reductive elimination
on the glycosyl chloride by lithium wire in liquid 
(49}ammoniav '. This reaction worked extremely well and 
always gave good yields of the crude glycal which was 
easily purified by column chromatography. This product's 
structure was confirmed by spectral analysis. IR data
showed the reappearance of an OH stretching peak at 3200-
— l 13550 cm and the H NMR spectrum contained all the 
desired signals including the indicative OH at 2.45 ppm 
and the olefin multiplets at 5.15 and 6.50 ppm.
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Scheme 12
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O
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An important experimental procedure during the 
chromatography was the addition of 2% Et3N to the mobile 
phase. Without this added base the glycal (35) was 
unstable to the acidity of the silica stationary phase, 
undergoing an important and well known reaction termed
-51-
the Ferrier rearrangement. This led to the production of 
the hemi-acetal (42) (Scheme 13) which contained 
undefined stereochemistry around the anomeric carbon *. 
This Ferrier product (42) was isolated from 
chromatographic columns run on the crude glycal (35) 
without the addition of Et3N. The structure of (42) was 
subsequently confirmed by spectral data. With this 
important fact in mind the desired furan allylic alcohol 
(35) was thus available in multi-gramme quantities for 
use in Claisen and aza-Claisen rearrangements.
Scheme 13
»H
(42) -52-
2.2 CLAISEN REARRANGEMENTS
2.2.1 Background
The Claisen rearrangement^54  ^has wide applicability 
in a variety of organic syntheses and was first described 
by Ludwig Claisen^55  ^ in 1912. However, it was not until 
20 years later that two groups investigated the aliphatic 
rearrangement noted by Claisen using the model compound 
B-cinnamyloxycrotonate (43). Bergmann and Corte^56  ^
employed Claisen's conditions using ammonium chloride 
catalyzed exchange of cinnamyl alcohol with ethyl 3-
ethoxy-2-crotonate for the formation of (43). Lauer and
(57 ^Kilburnv 1 used sodium cmnamylate and ethyl B- 
chlorocrotonate to form (43).
[^ - ph
0
(43)
Ph
(44)
,Ph
C02Et
(45)
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The rearrangement step was performed by both groups with 
ammonium chloride as catalyst. Bergmann and Corte 
obtained both (44) and (45) whereas only the desired 
rearranged product (45) was observed by Lauer and 
Kilburn.
The first practical example of the preparation ofi
gamma-delta-unsaturated carboxylic acids using the
/ eg \aliphatic Claisen rearrangement was by Arnold et a r  ' 
in 1949 (Figure 7).
Figure 7
(i) c o 2h
Ph Ph
(46)
(i)
Ph <47>
Reagents: (i) C6H2 (Me)3MgBr/ Et20
C02h
Ph Ph
The rearrangement was performed on (46) and (47) using 
mesitylmagnesium bromide at ambient temperatures. A 
variation of this method was the use of sodium hydride as/ eon \the base in refluxing toluenev }. Important for our
( 59 }project was the work of Burgstahler and Nordinv ' who 
were able to demonstrate that the Claisen rearrangement
-54-
was successful in a system where at least one of the 
double bonds was contained within a ring.
OH
0 0
(i)
(ii).
CHO
Reagents: (i) ROCH=CH2/ Hg(OAc)2, (ii) heat
While exploring the chemistry of triethyloxonium
fluoroborate Meerwein et al^61  ^ discovered a route to
f 62 ^N,N-dimethylformamide diethyl acetal. Eschenmoser'1 ' 
took this class of compounds and reacted them with 
allylic alcohols to produce, after rearrangement, 
gamma,delta-unsaturated amides. This rearrangement of 
amide acetals has since become a very useful synthetic
/ go Ntool. Buchi et all } employed this reaction in the 
production of a range of alkaloid derivatives and more 
recently Jenkins and his co-workers^64  ^used the amide 
acetal rearrangement in the synthesis of 2,3,3- 
trisubstituted cyclohexenes (Figure 8 ).
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Figure 8
OH
(i) (CH3)2N>
Reagents: (i) MeC(OMe)2NMe2/ heat
A very useful and simple addition to the array of 
Claisen rearrangements was discovered by Johnson et 
ai(65) When his group investigated the acid catalyzed 
exchange and subsequent rearrangement of ethyl 
orthoacetate with allylic alcohols to yield gamma^elta- 
unsaturated esters (Figure 9). This has since become a 
widely published method^66  ^with many uses in organic 
synthesis ^ 67 ^ .
Figure 9
HO OH
(i)
Et02CCH2
/~\
CH2C02Et
Reagents: (i) HeC(OEt) / propionic acid/ 138 / 3 hrs
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An interesting breakthrough occurred with the 
publication of Ireland's^60  ^ work in this field where he
used lithium dialkylamide bases to produce ester enolates 
which could undergo rearrangement at ambient temperatures 
(Scheme 14). Both the enolates and their O-silyl ketene 
acetals underwent facile rearrangement to yield 
gamma,delta-unsaturated acids.
Scheme 14
upon deprotonation with LDA and silylation with TMSC1 
underwent the Claisen rearrangement yielding ©C -fluoro 
carboxylic acids (Figure 10).
Figure 10
( (ii)
0
Reagents: (i) LICA/ THSC1, (ii) H30+
A variation of Ireland's work was performed by
/ go \Welch'' ' when he produced allyl fluoroacetates which
0 0
Reagents: (i) a) LDA, b) TMSC1, c) H20
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/ go \Davidson and his co-workers' ' also used a variant 
of the Ireland ester-Claisen rearrangement in their 
synthesis of the antifungal agent ambruticin. They 
produced tertiary sulphone esters and used them to 
prepare gamma,delta-unsaturated sulphones in a highly 
stereocontrolled manner (scheme 15).
Scheme 15
0
H
(ii)
\ r
Reagents: (i) pyridine/ CHC13/ (PhSC>2CH2C(0) )20
(ii) LDA/ TMSCl
Claisen rearrangements are classified as [3,3] 
sigmatropic reactions which are highly exothermic, 
concerted pericyclic reactions with a characteristic 
negative entropy. The exact structure of the transition
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state encountered during the rearrangement is still open 
to some speculation but it must obviously involve a high 
degree of resonance stabilisation. These highly ordered 
transition states effect a reliable transfer of 
stereochemistry from starting materials to products such 
as the asymmetric induction observed with chiral 
substrates as shown in figure 1 1.
Figure 11
It is also important to note that the primary chiral 
centre is destroyed during the rearrangement in what is 
termed a self-immolative process.
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2.3.2 Claisen Rearrangements on Furan Allylic 
Alcohol (35)
For the research project it was decided that a 
variant of the Ireland-ester Claisen rearrangement would 
be employed. Ireland had previously used acid chlorides 
to furnish the desired ester for rearrangement (Figure 
12) where X and Y are CH3 or H.
_rJrgure_3,2
Reagents: (i) a) XYCHCOC1, b) LDA, c) TMSCl, d) heat
The acid side chain produced would appear to be a 
useful synthetic 'handle' for a linear synthetic build up 
of the required heterocyclic base moeity. Its 
suitability would however be enhanced by replacing the X 
and Y groups with something more useful synthetically, 
such as OMe or SPh. With these groups attached a route 
becomes available to an oC. -ketoester side chain which is
(i)>
OH
(35)
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known to be useful in the synthesis of C-nucleosides such 
as showdomycin^70^.
Firstly the desired bis(phenylthio) acid chloride 
(49) was formed in a three step process (Scheme 16). 
Scheme 16
Cl2CHC02Et -------------- > (PhS)2CHC02Et
IIlI
*
(PhS)2CHCOCl (49) <-------------  (PhS)2CHC02H (48)
The first two steps were trivial and gave the acid (48) 
as a white solid in good yield (73%) which exhibited the 
characteristic OH stretching peak for a carboxylic acid 
in the IR spectrum covering the region 2500-3300 cm”1.
The next stage was the chlorination of the acid to 
produce the desired acid chloride. Initial reactions 
using the classical reagent of thionyl chloride proved 
unsuccessful with the final compound decomposing during 
the isolation procedure of vacuum distillation. The main 
breakdown product of this thermal decomposition was 
rather unexpectedly PhSSPh. The mechanism of this 
rearrangement is unknown but it must involve considerable
molecular fragmentation. This structure was confirmed by
l . . .H NMR, IR and MS analysis of the solid isolated from the
distillation. Employing the milder reagent oxalyl
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chloride in dry CH2C12 gave a crude product whose 
spectral data showed it was substantially the desired 
acid chloride. In the IR spectrum of the acid (48) the 
carbonyl peak occurred at 1690-1730 cm”1 whereas no such 
peak was witnessed in the data for the acid chloride 
crude product. Only the expected and desired C=0 peak at 
1750-1820 cm”1 indicative of acid chlorides was present. 
The 1H NMR spectrum of the crude material only contained 
signals at 4.85 and 7,2 ppm correlating to the CH and 
aromatic groups expected and no contaminant peaks were 
observed. No attempt was made to purify this product by 
distillation because of worries about decomposition, but 
it could be purified by rapid column chromatography. The 
acid chloride both crude and purified, was used in a 
modified ester Claisen rearrangement employing Ireland's
(49 \conditionsv '. Numerous attempts at the reaction all 
yielded complex mixtures, with no single major product 
being formed. Column chromatography of these crude 
reaction mixtures allowed isolation of the various 
products observed. No attempt was made to assign a 
structure to each compound, merely a comparison was made 
with the expected data for the desired product. 
Unfortunately none of the compounds isolated from the 
mixture was the required branched acid product.
Due to the rather disappointing results achieved with 
the Ireland-ester Claisen rearrangements attention was
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focussed onto other methods of obtaining the desired 
products. The obvious choice at first appeared to be 
Johnson's^65  ^ acid catalzed ethyl orthoacetate 
rearrangement and this reaction was attempted employing 
trimethyl orthoacetate as both substrate and solvent with 
propionic acid as the catalyst.
0 .
V p ><
>
0
co2ch3
HO (35) (50)
Reagents: (i) MeC(OMe)3/ propionic acid
The single product obtained after 3 hours reflux was not 
the desired methyl ester (50) as 1H NMR analysis and 
comparison with previous recorded spectra showed the 
product to be the Ferrier rearranged alcohol (42). This 
compound was subsequently stable to the reaction 
conditions employed, showing no tendency to undergo a 
Claisen rearrangement itself.
The Johnson-Claisen rearrangement could not 
therefore, be used in the furan system compounds due to 
the acidic conditions required for reaction. A method of 
Claisen rearrangement was thus required which employed 
non-acidic conditions and the obvious choice was an amide
-63-
acetal rearrangement. Dimethylacetamide dimethylacetal 
was reacted with the allylic alcohol (35) in refluxing o- 
xylene (Figure 13).
Figure 13
Reagents: (i) dimethylacetamide dimethylacetal/ o-xylene
heat/ 64 hrs
Initially the starting materials were simply added 
together in one pot and refluxed over 64 hours under a 
positive pressure of nitrogen. Following removal of the 
volatiles, TLC of the crude material showed the reaction 
had proceeded to generate a single product. Column 
chromatography yielded the pure rearranged amide (51) in 
71% yield as a clear colourless gum. No OH peak was 
visible in the IR spectrum thus confirming complete 
disappearance of the starting alcohol (35) and the 
appearance of a C=0 peak at 1679 cm*1 suggested the 
presence of an amide functionality. Characteristically 
in the 1H NMR spectrum the presence of a singlet at 2.0 
ppm for the amide methyl groups and a shift of the olefin 
signals fromm 5.15 and 6.50 ppm to 5.95 and 6.1 ppm
OH (51)
-64-
confirmed that the desired rearrangement had taken place. 
Further experimentation attempting to both enhance the 
yield and shorten the reaction time was subsequently 
undertaken involving the use of a trap to remove the 
methanol produced during the rearrangement. Due to Le 
Chateliers principle this should have enhanced the yield 
but results obtained proved inconclusive. Future work 
could involve the use of better methods of methanol 
removal such as employing a soxhlet extractor filled with 
CaCl2 which again should help enhance the yield. The 
rearranged amide appeared to contain all the qualities 
required for use as an intermediate in novel C-nucleoside 
synthesis. The synthetic 'handle' side chain was present 
to allow heterocyclic base synthesis and the 
isopropylidene protecting group had the possibilities for 
a variety of interesting substituents to be made 
available. Finally the unsaturation between C2' and C3' 
might be extremely useful for the addition of a variety 
of functionalities. For instance, in order to produce 
another series of compounds in this area, one simple 
reaction was to reduce the double bond by hydrogenation 
employing a palladium on charcoal catalyst. This 
reaction was performed (Figure 14) and led to the 
saturated amide (52) being isolated in 88% yield. This 
compound (52) could prove useful in producing a series of 
2 ',3'-dideoxy nucleoside analogues.
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Figure 14
XDD
(51)
X: C(0)N(CH3 )2
(52)
Reagents: (i) Pd/C H.
2.4 AZA-CLAISEN REARRANGEMENTS
2.4.1 Background
As has been previously shown the Claisen 
rearrangement has proved a useful method for the 
production of intermediates in the synthesis of C- 
nucleosides. Although of interest, the C-nucleosides are 
not as biologically active in most cases as nucleosides.
A method of producing a sugar with a synthetic *handle' 
suitable for nucleoside synthesis could therefore prove 
extremely useful and such a reaction would appear to be 
what is commonly termed as the aza-Claisen or hetero- 
Claisen rearrangement.
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Prior to 1974 a generally useful method for the 1,3 
transposition of oxygen and nitrogen functions was not 
available (Figure 15, X=OH, Y=NR2)
Figure 15
RlR2C = C R — CR3R4  ►  R3R2C— CR=CRCR3R4
X Y
This is exactly the reaction which was required if
the furan allylic alcohol (35) was to produce a useful
intermediate for nucleoside synthesis. The reaction
shown in figure 15 would have wide applicability in a
variety of organic syntheses. Methods prior to 1974 for
effecting this rearrangement all had serious drawbacks.
The S^2 reaction of allylic alcohol derivatives with
amines can be successful but it relies on direct
displacement being precluded by steric and other 
( 71 ^factorsv '(Figure 16).
One of the most applicable processes was the base- 
catalyzed thermal rearrangement of allylic phenyl 
urethanes at 200-240°C (Scheme 17) but a drawback of this 
process is that always ionization (SNi) occurs and thus 
even in the best cases significant amounts of 
unrearranged compounds are isolated.
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Figure. X6
Cl
oo
Cl
H
(i)
Reagents: (i) 130
Scheme 17
RlR2C—  CR —  CR3R4
o c n c 6h 5
RlR2C— CR— CR3R4
CgHcN— C— OH * I O
(ii)
RlR2C— CR=CR3R4
h n c 6h 5
Reagents: (i) 200-240 , (ii) base/ heat
+ C02
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Another method of interest was the rearrangement of
corresponding amides. This again had serious problems in
that the yields to the required imidate intermediate are
moderate and also the high temperatures needed to effect
the rearrangement could disrupt the structure of the
amides produced.
With this lack of a generally applicable method for 0
to N transposition in mind, a breakthrough occured in
(74}1974 with the publication of a paper by Overmann' 7. In 
this paper he reported the facile [3,3]-sigmatropic 
rearrangement of allylic trichloroacetimidates to afford 
the corresponding trichloroacetamides (Figure 17). This 
synthetic operation results in the much sought after 1,3 
transposition of alcohol and nitrogen functions.
Figure 17
Overmann first prepared the intermediate allylic 
trichloroacetimidates from the corresponding alcohol and 
trichloroacetonitrile in almost quantitative yield and 
subsequently these imidates were easily thermally 
rearranged within a few hours in a high boiling solvent
( 72 }N-phenylformimidatesv 7 and allylic N- 
phenylbenzimidates^73  ^ at 200-250°C to yield the
CC13 CCI3
>
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such as m-xylene to furnish the desired 
trichloroacetamide product. A further interesting point 
was the observation that added mercuric salts often 
catalysed the rearrangement quite appreciably. The 
trichloroacetyl group could then be easily hydrolytically 
removed to yield the free amine. The great advantages 
over any previous method for 1,3 0 to N transposition 
included the much lower temperatures required to effect 
the rearrangement and the ease of removal of the 
trichloroacetyl group to yield the free amine.
This important reaction has since been used in a 
variety of syntheses. Overmann himself employed it in 
the production of the interesting natural alkaloid 
intermediate l-azaspiro[5,5]undec-7-en-2-onev ' (scheme 
18).
(76 }More recently Ichikawa' ' required the use of the 
aza-Claisen rearrangement as the crucial step in the 
synthesis of aminobisabolanes (Figure 18).
Figure_lJ.
OH NHC(O)CC13
Reagents: (i) a) NaH/ C13CCN, (ii) toluene/ reflux
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Scheme 18
OHI (i)
CC13
A™.
NHC(O)CCI3
Reagents: (i) NaH/ C13CCN/ 0°, (ii) hexane/ 69°/
4-5 days
Even though the conditions for the trichloroacetimidate 
synthesis are fairly mild, yields of the final acetamide
after rearrangement are still sometimes only modest.
This is due to competing decomposition of the imidate in 
the refluxing solvent, as compared with the desired 
rearrangement.
Savage and Thomas^77  ^ attempted to further eliminate 
this problem by the use of trifluoroacetonitrile instead 
of trichloroacetonitrile. [3,3] Rearrangements of 
allylic imidates are accelerated by the addition of 
electron-withdrawing substituents on the imidate carbon 
and therefore, by replacing chlorine with the more highly 
electro-negative element fluorine, they hoped for and 
achieved the effect of allowing the rearrangement to 
occur under even milder conditions. The only drawback 
for this method was that it employed trifluoro­
acetonitrile, which was more expensive than 
trichloroacetonitrile and as a gas was more difficult to 
handle in the laboratory.
2.4.2. Aza-Claisen Rearrangements on the Furan Allylic 
Alcohol (35)
For the basis of the project it was decided to employ 
Overmann's methodology^78  ^ using trichloroacetonitrile as 
opposed to the more expensive trifluoro derivative.
A clear colourless solution of the furan allylic 
alcohol (35) in dry ether was treated with a 0.1 mole
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equivalent of sodium hydride to produce the reactive 
alkoxide. After a period of twenty minutes hydrogen 
evolution had ceased and the bright orange clear liquid 
was transferred via syringe to a solution of 
trichloroacetonitrile (1 mole equivalent) at 0°C. 
Subsequent work up yielded a pale green liquid which 
crystallised upon standing and was presumed to be the 
trichloroacetimidate product. However, IR examination of 
this solid did not show the expected characteristic 
strong C=N str at 1660 cm”1, instead a peak at 1720 cm"*1 
was observed. This unknown solid was dissolved in dry 
toluene and refluxed to see if any rearrangement/reaction 
occurred. No reaction was observed and after work up and 
recrystallization the pure white crystalline solid 
isolated was analysed more closely. The appearance of a 
peak in the IR spectrum at 1720 cm"1 led to the 
possibility that this correlated for the C=0 stretching 
frequency expected in the desired trichloroacetamide 
product. This would signify that the intermediate 
imidate had rearranged in a facile manner to the 
trichloroacetamide (53) under the reaction conditions 
employed (Scheme 19).
Analysis by proton NMR, mass spectrometry and micro 
analysis confirmed the structure of the white solid as 
that of the coveted trichloroacetamide (53). In the 1H 
NMR spectrum the shift of the olefin signals from 5.15
-73-
and 6.50 ppm to 6.15 and 6.45 ppm indicated the 
rearrangement had indeed occurred and this was confirmed 
by the EI-MS of the solid which contained a molecular ion 
at 330 mass units as required for (53).
Scheme 19
0
0
OH
0
o
NH
X /■NHCO ' \
(53)
CC13
Reagents: (i) NaH, (ii) Cl.CCN/ 0
The yield of the reaction was modest (48%) but this still 
compared favourably with similar rearrangements attempted 
by other groups. The explanation for this novel facile 
rearrangement could be due to two possible reasons.
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Firstly the ring nature of the furan helps place the 
functional groups of the intermediate imidate into the 
correct spatial arrangement for rearrangement to occur. 
The main driving force for the reaction however is 
probably the fact that the furanose oxygen polarises the 
single bond with carbon (Figure 19) thus making 
nucleophillic attack on that carbon more favourable.
Figure 19
Further experimentation showed that the reaction 
worked equally well with anywhere up to 1 mole equivalent 
of sodium hydride with little effect on the overall 
yield. A further benefit discovered was that impure 
glycal (35) could be employed again with little or no 
effect on the yield. The reaction is however fairly 
water sensitive and it was discovered that the use of 
ether freshly distilled from LiAlH4 had a marked positive 
effect on the yield. Thus by following these guidelines 
the reaction yield was optimised to 78% and so the
\CC13
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trichloroacetamide (53) became easily available in multi­
gramme quantities.
The next stage of the reaction scheme, the hydrolysis
of the trichloroacetyl group to the free amine, appeared
rather trivial. From this amine a variety of well
published methods are available for the linear synthesis
of the required heterocyclic bases. Following Overmann's 
f 78 ^method1 1 it was therefore attempted to hydrolyse (53) 
with aqueous NaOH in ethanol at room temperature. After 
36 hours the starting material had been consumed leaving 
a product lying on the baseline of the TLC plate. Even 
by employing highly polar solvents such as methanol this 
product spot could only be moved to Rf=0.10. Initial IR 
and proton NMR analysis appeared to suggest that the 
desired free amine had not been produced. A variety of 
reaction conditions were attempted in order to produce 
the amine with the quantity of NaOH used appearing to 
have no affect on the reaction as did alteration of the 
reaction temperature.
After much experimentation it was decided that the 
amine was probably unstable and not isolable under the 
reaction conditions being employed. Hydrogenating the 
double bond of the trichloroacetamide (53) was thought to 
be a useful way of lowering the reactivity of the amine 
produced by hydrolysis. Initially the hydrogenation wasi
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attempted using Pd on charcoal as catalyst and ethyl 
acetate as the solvent. These conditions produced a 
highly polar product which was extremely difficult to 
isolate. IR analysis of this polar compound showed both 
0-H str. and C=0 str peaks which appeared to suggest 
that the isopropylidene protecting group had been 
cleaved. This was confirmed by proton NMR by the loss of 
the signals for this group at 1.35 and 1.42 ppm and thus 
this spectral analysis showed the compound produced was 
the diol-acetamide (54). The Pd catalyst had not only
hydrogenated the olefin as required but also the 
trichloroacetyl group had been hydrogenolysed to the 
acetamide which was confirmed by the loss of the chlorine 
isotope pattern in the EI-MS and by the appearance, in 
the proton NMR, of a signal for the amide methyl group at
2.1 ppm. The HCl produced during this hydrogenolysis was 
sufficient to facilitate the cleavage of the 
isopropylidene protecting group leaving the diol. The 
next hydrogenation was therefore performed with Adams' 
catalyst (PtO), a milder hydrogenating agent and with 
Et^N added to the solvent to react with any free HCl.
The resultant product (55) from this procedure was 
isolated in good yield (89%) and again showed 
hydrogenolysis of the trichloroacetyl group but this time 
the isopropylidene had remained intact. The amide (55) 
still presented difficulties for its use in the synthesis 
of the desired free amine. This was due to the
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difficulty in hydrolysing the amide without the use of 
acidic conditions which would disrupt the molecule's 
structure.
(55)
Reagents: (i) Pd/C H2, (ii) PtO/ H2/ Et3N
If the trichloroacetamide was to prove a useful 
intermediate for nucleoside synthesis either methods for 
the non-acidic hydrolysis of (55) or ways of reducing the 
olefin of (53) specifically with no accompanying 
hydrogenolysis would need to be found.
Two olefin specific reducing agents are diimide and 
Wilkinson's catalyst. Diimide (NH=NH) is formed from 
N2H4 and an oxidising agent as both its syn and anti 
forms, although only the syn form reduces the double
-78-
bond, probably in part via a cyclic mechanism (Figure 
20).
Figure 20
The addition is stereospecifically syn and takes place, 
in general, from the least hindered side of the double 
bond. As can be seen from its mode of action a diimide 
would be unable to effect the undesired side reaction of 
trichloroacetyl hydrogenolysis.
Wilkinson's catalyst (chlorotris(triphenylphosphine) 
rhodium, RhCl(Ph3P)3) is known to catalyze the 
hydrogenation of many olefinic compounds without 
disturbing such groups as COR, COOR, N02 and CN present 
in the same molecule. This reagent is a homogeneous 
catalyst and can be employed in a variety of organic 
solvents. Both Wilkinson's catalyst and diimide could 
therefore be employed to attempt the specific reduction 
of the olefin in order to produce the desired saturated 
trichloroacetamide. Unfortunately due to lack of time 
neither of these methods were actually tested.
Due to the lack of success in isolating the free
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amine it was decided to seek other methods of employing 
the trichloroacetamide (53) to produce nucleoside 
analogues. An initial thought was that nucleophilic 
attack at the amide carbonyl might induce the 
displacement of the trichloroacetyl as a leaving group. 
This would be of extreme interest if the nucleophile 
could be of a type which would produce an urea derivative 
(Figure 21)
■ ■.rjL.gure_23-
(53)
Reagents: (i) HNR'R"
Ureas have often been used as building blocks for the 
synthesis of heterocyclic pyrimidine bases. Initial 
experimentation using sodamide in dry THF did not show 
any reaction, possibly due to the lack of solubility of 
sodamide in THF. A variety of reaction conditions such 
as varying the quantity of sodamide employed and the 
temperature of the mixture appeared to make no apparent 
difference to the reaction outcome. In a subsequent 
reaction the trichloroacetamide (53) was dissolved in dry 
THF and gaseous ammonia was bubbled through the stirred
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mixture, but reaction for 48 hours at room temperature 
led only to recovery of starting materials. Similarly 
(53) was dissolved in ethanol and conc. ammonia was added 
and the reaction vessel stoppered. After 48 hours 
removal of the volatile components gave the crude 
material as a complex mixture from which the desired 
product was not isolated.
An interesting paper by Antanassova et al^79  ^
appeared to show a use for trichloroacetamides which was 
of great relevance to this work of urea derivative 
synthesis. Antanassova and his co-workers reacted 
trichloroacetamides with carboxamides in the presence of 
excess powdered NaOH in DMSO to yield acylureas (Figure 
22) via their in situ generated isocyanates. This would 
appear to show an easy route to the synthesis of urea 
analogues potentially useful in the synthesis of 
nucleoside derivatives. Only very tentative initial 
experimentation has been performed using this method with 
the trichloroacetamide (53) being reacted with the model 
compound benzamide to yield a complex mixture of 
products. Further work is needed in this interesting 
area in order to assess its viability as a route to urea 
intermediates useful for nucleoside analogue synthesis.
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Ficnire 22
OXN CCI3 H
(i)
■NH
Reagents: (i) DMSO/ NaOH/ 80°
A possible method of purine heterocyclic base 
synthesis would be that described numerous times in 
literature as the reaction between an amine and a 
dichloropyrimidine derivative^80^. Although the free 
amine was not available at present an attempt was made to 
perform this reaction on the trichloroacetamide (53) 
(Figure 22) by trapping the intermediate amine in situ.
Figure 22
Cl
0.
0 ‘ NHC(O)CCI3 X
u
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Following 36 hours reflux all the starting material had 
been consumed leaving a mixture of starting pyrimidine 
and baseline material by TLC. Analysis by IR, proton NMR 
and El-MS failed to aid in the elucidation of the 
product/s formed by this reaction.
2.5 Use of Glycal (35) and its Ferrier Rearranged
Derivative (42)
The product of the Ferrier rearrangement, the cyclic 
hemi-acetal (42), has been mentioned previously in this 
report and was formed by acid catalysis during a 
trimethyl orthoacetate Claisen rearrangement of the 
glycal (35). If the glycal (35) or its rearranged 
derivative (42) could be reacted to produce their acetyl 
derivatives a number of possibilities become applicable 
for the convergent synthesis of nucleoside analogues.
One obvious method would be to employ the reaction of 
(56) with a purine heterocyclic base in the presence of a 
Pd catalyst^43  ^ (Figure 23).
Initial attempts to produce the acetate of glycal 
(35) employing nbutyllithium and distilled acetyl 
chloride were unsuccessful with starting material and an 
unknown product being recovered. Reaction of the glycal
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Figure 23
Cl
r r  OAc
(56)
(i)
Reagents: (i) 2-amino-6-chloropurine/ NaH/ Pd(PPh3 )4
(35) with acetic anhydride in pyridine with DMAP as 
catalyst led, after 54 hours at room temperature, to 
recovery of starting materials. Refluxing this mixture 
overnight and removal of all the volatiles produced a 
black gum which showed signs (IR? C=0 str.) that the 
acetate had been formed. However, TLC and proton NMR 
appeared to show that this was probably a minor product 
only. Unfortunately due to a lack of time no further 
work was possible in this area.
( 81 ^A very recent paper by Pearson and Schkeryantzk ' 
describes the nucleophilic displacement reactions of 
allylie alcohols and their acetates in the presence of 
LiClO^ (Figure 24). If the nucleophile employed could 
for instance be a silylated pyrimidine or purine base 
this would be a novel and simple route to a range of 
nucleoside analogues.
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Figure 24
Ar + CH2 :CH(OTBDMS)OEt
OH
Ar
CH2C02Et
An initial reaction using this methodology was 
attempted employing glycal (35) with indole as the model 
nucleophile, in the presence of LiClO^ (Figure 25).
 Figure_25
Reagents: (i) LiClO^/ indole
After 12 hours at room temperature TLC showed no reaction 
had occurred and upon work-up only starting materials 
were recovered. It would be hoped that if the acetate of 
the glycal could be isolated this might prove to be more
H
(i) >
OH
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successful. If reaction was shown to take place with a 
model nucleophile this method could prove very useful in 
nucleoside synthesis. A change in nucleophile to a 
silylated pyrimidine or purine base could prove to be 
both a novel and easy route to a range of nucleoside 
derivatives.
2.6 Summary and Future Work
The Claisen amide-acetal rearrangement of the glycal
(35) works well but little work has been attempted in its
uses as a precursor to C-nucleosides. A possible route
f 67 ^for its use is discussed by Tulshian and Fraser-Reid1' ' 
whereby the amide is reduced with Li(OEt)3AlH to produce 
an aldehyde functionality (Figure 26). From this 
aldehyde a number of possibilities for C-nucleoside base 
build up are available.
Figure 26
— 0
NMe2
Reagents: (i) Li(OEt)3AIH
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The aza-Claisen rearrangement on the glycal (35) has 
produced interesting results in so much that the 
rearrangement is facile under the reaction conditions 
employed. Typically refluxing in a suitable solvent is 
required to effect the rearrangement step. Unfortunately 
little success has been forthcoming in the hydrolysis of 
this amide to produce the free amine which would be an 
intermediate of great use in nucleoside analogue 
synthesis. Certainly areas which require much greater 
examination are the use of trichloroacetamides to produce 
urea derivatives and the reduction of the double bond of 
trichloroacetamide (53) by reagents such as Wilkinson's 
catalyst and diimide in an attempt to moderate the 
reactivity of the free amine and thus permit its 
isolation. Czernecki's paper would seem to be an 
extremely interesting one concerning the reaction of 
trichloroacetamides to produce urea derivatives which 
could prove very useful as intermediates in nucleoside 
synthesis.
Finally in this furan area is the use of the glycal 
(35) or its Ferrier rearranged product (42) as their 
acetate derivatives. As yet the acetates have not been 
isolated but with further experimentation using acetic 
anhydride and DMAP in refluxing pyridine it should be 
possible to furnish the desired product. The use of 
these acetates in conjunction with LiC104 and a silylated
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heterocyclic base could provide a quick and easy method 
of chiral nucleoside synthesis. As previously discussed 
these acetates could also be employed in the more 
standard reaction with a chlorinated heterocyclic base in 
the presence of a Pd catalyst to furnish a nucleoside 
derivative. A further possible use for the glycal (35) 
is highlighted m  a paper by Farr and Davesv '. The 
glycal alcohol is initially protected as the t-butyl- 
diphenylsilyl ether. Subsequent reaction of this silyl 
protected compound with the mercury salt of a 
heterocyclic base in the presence of palladium acetate 
catalyst produced an interesting C-nucleoside derivative.
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3.0 CARBOCYCLIC NUCLEOSIDES
3.1 Introduction
The major disadvantage of furan based nucleoside 
analogues as antiviral agents is their instability to 
degradative enzymatic fission in the body. An example of 
this is shown by the antiviral compound E-5-(2- 
bromovinyl)-2'-deoxyuridine (BVDU) (57) which is removed 
from the blood stream within two hours of administration.
0
Br
HO.
OH
(57)
As has been previously stated it is the glycosidic 
—O-C-N- linkage between the sugar and base moieties which 
is enzymatically hydrolysed and therefore alterations of 
the sugar or base entities would hopefully produce 
nucleoside analogues that exert interesting and powerful 
biological activity. Replacement of the furanose oxygen 
atom for instance with a methylene group would produce
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the range of cyclopentane analogues better known as 
carbocyclic nucleosides. The hydroxy and base groups 
occupy the same positions, have the same spatial 
relationships and may be expected to assume the same 
conformations as their nucleoside analogues. Thus the 
carbocyclic derivatives have the potential either to 
mimic or antagonize the functions of the naturally 
occurring nucleosides and nucleotides. The other major 
advantage of these carbocyclic analogues is that they no 
longer contain the -O-C-N- linkage which is so easily 
degraded by bodily enzymes. The carbon-nitrogen bond 
joining the heterocyclic base to the cyclopentane ring 
should be comparable in stability to that of a simple 
alkyl derivative and so should be less susceptible to 
this enzymatic degradation. A further possible advantage 
is that carbocyclic nucleosides offer the possibility of 
being more selective antiviral agents than their 
nucleoside analogues. This is due to the more stringent 
substrate requirements of the mammalian kinase enzymes as 
compared with those of the virally coded enzymes of 
infected cells. The majority of carbocyclic nucleosides 
are synthetic in nature but several of natural origin 
have been discovered such as (-)-aristeromycin (58) and 
(-)-neplanocin (59).
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Recently carbaoligonucleotides have been prepared for
the first time^82  ^ and for their synthesis a reasonable
supply of enantiomerically pure carbocyclic nucleosides
is required. The synthesis of such a supply requires a
different methodology to that used in classical
nucleoside synthesis due to the lack of an acetal moiety.
A variety of other methods for carbocyclic nucleoside
synthesis have been employed such as the initial work by
( 32 )Shealy and Clayton' * who constructed the heterocyclic 
base from an amino group positioned on the cyclopentane 
ring. Another useful method of synthesis is the direct 
displacement of a suitable leaving group located at Cl by 
a base. A further strategy uses nucleophilic opening of 
an epoxide by base from which carbanucleoside connection 
and generation of a hydroxy group is accomplished 
simultaneously. This methodology has been used by 
Roberts^41  ^ for opening the epoxide (60) with 2-amino-6-
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methoxypurine in DMF at 145 C using lithium hydride as a 
catalyst to produce (61). Deoxygenation and deprotection 
of (61) yielded the carbocyclic nucleoside 2 '-deoxy- 
guanosine (62) (Scheme 20).
Scheme 20
PhCH20
PhCH20
(60)
(i)
PhCH20.
PhCH20
(61) 
(ii)
Reagents: (i)
(ii) a) H2 Pd/C, b) HCl/ 80'
(62)
-94-
Similarly to the work in the furan system the first 
synthetic objective for this section was the production 
of suitable allylic alcohol upon which the Claisen and 
aza-Claisen rearrangements could be performed. It was 
decided that a modified method of Paulsen and MaaB^50  ^
would lead to such a useful carbocyclic allylic alcohol 
of the general structure (63)
0
(63)
ROi
OH
(36)
3.2 Synthesis of Carbocyclic Allylic Alcohol (36)
The initial reaction in the scheme (scheme 21) was 
the protection of an B-ketoester as its ethylene ketal. 
Classically this reaction is performed with ethylene 
glycol and tosic acid employing benzene as the solvent 
but due to the high toxicity of benzene it was thought 
prudent to substitute this for the less harmful 
alternative of toluene. Early reactions using Dean-Stark 
apparatus for capture of the water azeotrope gave rather
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unpromising results as the crude product isolated after 
work up was a black viscous liquid which contained a 
complex mixture of products. Purification of this crude 
mixture by distillation did not give the pure product and 
the yields obtained were substantially lower than was to 
be expected (25% as compared with literature 56%).
Column chromatography also proved ineffective as a method 
of purification and so the initial commercially supplied 
ethyl ester (63) was substituted with laboratory 
synthesized methyl ester analogue. Reactions using this 
methyl ester provided comparable results to the ethyl 
ester.
A model reaction was thus tried employing the exact 
conditions cited by Paulsen and MaaB which meant using 
the undesired solvent benzene. After base work-up the 
crude product appeared as a clear pale green liquid. 
Analysis by 1H NMR, IR and MS showed the mixture to 
contain almost solely the desired ketal product (64). 
Particularly characteristic was the appearance, in the H 
NMR spectrum, of a singlet correlating for the 4 
hydrogens of the ketal protecting group. The only 
contaminant was a slight amount of benzene and this was 
easily removed by distillation which also allowed 
isolation of the ketal (64) as a clear colourless liquid 
in excellent yield (76%). However, for general use in 
the synthetic scheme 21 it was unnecessary to purify this
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ketal, as the crude material was sufficiently pure for 
use in the next reaction. It is presumed that the 
failure of the ketalization in toluene was due to the 
higher reaction temperature required, in comparison with 
benzene.
Scheme 21
0
C02Et
(63)
r~\
(64a)
The next synthetic step was to reduce the ethyl ester 
to its primary alcohol with LiAlH^, a reaction which was 
easily performed on a large scale in dry ether at 0°C. 
Typically the work-up of a LiAlH4 reaction involves the 
use of acid to aid dissolution of the lithium and 
aluminium salts in aqueous medium from which the desired 
product may be isolated by solvent extraction. This was 
not possible in this scheme as the ketal would have been 
hydrolysed under the acidic conditions employed, a
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° ^ °><r,co2Et
(64)
problem which was solved by the addition of a molar 
equivalent of NaOH. This NaOH precipitated out the 
unwanted salts and so subsequent filtration and careful 
washing of the filtrate yielded the crude alcohol as a 
clear colourless liquid in virtually quantitative yield 
(98%). IR analysis confirmed the reaction had gone to 
completion by the total disappearance of the C=0 str at 
1725 cm”1 due to the ester and the subsequent appearance 
of the expected 0-H str. at 3250-3600 cm of the product 
alcohol. No further purification of this compound was 
necessary.
It was the next four steps of the reaction pathway 
which were to prove the most crucial in the production of 
the final allylic alcohol (36) (scheme 22). Protection 
of the primary alcohol was to be followed by a 
bromination/dehydrobromination procedure to insert the 
double bond allylic to the ethylene ketal. Deprotection 
of the ketal with acid would furnish the oc ,B- 
unsaturated ketone (65) which by a simple reduction 
would thus provide the final desired allylic alcohol (36) 
product.
The first step therefore was the protection of the 
primary alcohol of (66) which was important as it would 
have serious effects on later stages of the synthesis.
It was hoped that a rather bulky group could be used to
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protect the alcohol which would subsequently sterically 
Scheme 22
r~\
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(68)
OR
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direct the hydride attack, during the final ketone 
reduction onto the lower face of the cyclopentane ring. 
This would therefore produce the desired cis 
configuration of alcohol to protecting group. A variety 
of bulky protecting groups exist and one obvious choice 
was trityl (triphenylmethyl ether), but the usefulness of
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this group was questionable as its stability to the 
acidic ketal deprotection was unknown. Therefore a more 
suitable acid stable functionality was required and 
other possible protecting groups of use would include 
esters or one of the range of silicon moieties such as 
the particularly useful bulky tert-butyldiphenylsilyl 
group.
The primary alcohol of (66) was thus reacted to produce 
compounds with a wide variety of protecting groups 
attached (Figure 27).
Ficrure 27
(66)
/ \
(68)
when R= Me compound=68a
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The bromination/dehydrobromination reaction was to 
possibly prove the most crucial in the reaction pathway. 
The ketal which had already protected the ketone from 
attack by LiAlH^ now took on its next crucial role in the 
bromination mechanism. Bromination/dehydrobromination 
alpha to a naked carbonyl is a somewhat finnicky reaction 
and so this type of reaction is best handled via thei
ketal of the carbonyl. The ketal of an enolizable ketone 
readily forms the related enol ether in the presence of a 
catalytic amount of acid. This enol ether is very labile 
to electrophillic attack and so not surprisingly bromine 
will react with it instantaneously ultimately leading to 
the -bromoketal (67) (scheme 23).
Scheme 23
r ~ \
.+
— H+ / ^ O H0
(67)
( 83c )Garbisch' ' has shown that further addition of a 
second bromine onto the same carbon is not possible
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without much harsher reaction conditions. A particular 
advantage of using ketals is that dehydrobromination can 
easily be achieved with a variety of strong bases. The 
dehydrobromination of an ©L -bromocarbonyl is on the 
other hand open to many damaging side reactions and so 
with this knowledge an initial reaction was performed 
using the methyl ether protected compound (6 8). Ethylene 
glycol was used as the solvent for the reaction but 
during the addition of the bromine it was not possible to 
maintain the light straw colouration discussed by Paulsen 
and Maafc at the temperature of <20°C. Isolation of the 
oc-bromoketal intermediate product was followed 
immediately by dehydrobromination with anhydrous NaOMe in 
dry DMSO. H NMR analysis of the crude product showed 
the appearance of a trace amount of olefinic material by 
the appearance of multiplet signals at 5.67 and 6.06 ppm. 
and subsequent purification by column chromatography 
furnished the desired allylic ketal in poor yield (10%). 
Following this disappointing result a variety of reaction 
conditions were employed in an attempt to optimize the 
reaction yield. This optimization initially entailed 
monitoring the effect, if any, of altering the contact 
time of the bromine with the methyl ether (6 8). Thus 
reactions were carried out where the methyl ether was 
left stirring with bromine for periods ranging from 10 
minutes to 2 hours. This variable seemed to have 
surprisingly little effect on the overall yield of the
- 102-
reaction. Other variables observed included the rate of 
bromine addition and the temperature at which volatiles 
were removed during isolation of the intermediate bromo- 
ketal (67). The rate of addition of bromine had little 
effect on the yield, but, the concentrating temperature 
did have a dramatic effect. At temperatures <15° all the 
bromide formed remained intact but as the temperature 
rose above 20° substantial decomposition of this 
intermediate occurred, leading to poor yields of the 
final alkene product. The most important point noted was 
however, that the bromination often required an initial 
amount of heating (>45°C) to initiate the reaction. Once 
this initiation had occurred it was possible to add the 
bromine so as to keep the light yellow colouration 
throughout the addition as required. This initiation 
with heat led to a great enhancement and better 
reproducibility in the yields of (69) obtained. 
Substituting NaOH in EtOH for anhydrous NaOMe in DMSO 
made for a far easier experimental procedure and little 
derogatory effect on the yield was noticed. Thus by 
isolating the bromide at low (<20°) temperatures and 
initiation with a little heat the reaction was optimized 
to an adequate yield of 68%.
With the bromination/dehydrobromination reaction 
optimized using the methyl ether (6 8), a variety of the 
other protected compounds synthesized were reacted under
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the same conditions. When using TBDMS and TBDPS 
protected alcohols no bromine decolourization could be 
noted when employing ethylene glycol as solvent and 
following the subsequent dehydrobromination a complex 
mixture of products was isolated. The benzoate and 
pivaloate esters produced similar results. In the case 
of the pivaloate ester however some olefinic compound was
isolated from the dehydrobromination stage and its
lstrucure confirmed by H NMR, IR and MS analysis. This 
reaction only produced the desired product when ^BuOK had 
been substituted for anhydrous NaOMe. The yield was poor 
(<15%) and subsequent reactions gave a variety of yields 
ranging from 0% to 15% and thus the reaction was 
disregarded for use in the synthetic scheme 22. Other 
compounds also tried were the benzyl ether, the 
monomethoxymethyl ether and the trityl ether. Reaction 
of these compounds merely led to recovery of starting 
materials with no olefinic material isolated.
A possible reason for this lack of reaction and/or 
poor yields with a variety of the protected alcohols was 
the insolubility of the starting materials in ethylene 
glycol. Even with vigorous stirring the compounds were 
still visible as large globules rather than the required 
fine dispersion. Three different methods were thus 
employed to determine if it was this solubility factor 
which was determining the lack of reaction. Two of the
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methods are closely related in that they employ compounds 
which when dissolved in a suitable solvent act as free 
bromine. The use of pyridinium hydrobromide
for the oL -bromination of steroid ketones. More
syntheses where ethylene ketals have been used as 
intermediates for bromination/dehydrobromination 
reactions (scheme 24). Pyridinium hydrobromide 
perbromide is a useful brominating agent as it is a 
stable and crystalline salt which can, in contrast to 
bromine, be weighed out accurately on a micro or semi 
micro scale.
Scheme 24
perbromide^84  ^ was first cited by Djerassi and Scholz^85^
recently Eaton (83b,86) has employed it in a variety of
base
v
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Initial brominations of the methyl ether compound (68a)
in dry THF and subsequent dehydrobromination with ^BuOK
\led to yields comparable with those previously obtained 
using bromine and NaOMe. Reaction with the silyl and 
ester protected alcohols was therefore attempted but in 
all cases a mixture of products was isolated with no 
double bond character being observed in the proton NMR 
spectrum.
The second alternative bromination attempted was
closely related to the method previously discussed with
the compound trimethylammonium tribromide being used in
( 87 )dry THF. This methodology was employed by Marquetv ' to 
brominate alpha to ethylene ketals during a steroid 
synthesis (scheme 25). Again this reagent gave good 
results when used in conjunction with the methyl ether 
(68) but complex mixtures where obtained when either the 
silyl or ester protected compounds were used.
Finally brominations were carried out using elemental 
bromine employing dry THF as the solvent as opposed to 
ethylene glycol. An initial difficulty encountered with 
this method was that accurate measurement of the mass or 
volume of bromine to be used was very difficult on a 
small scale. This subsequently led to a variety of 
products being formed, possibly due to over or under
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Scheme 25
AcO
[Br]
Br
AcO'
base
AcO
bromination caused by incorrect amounts of bromine being 
added.
A further reason for the failure of the bromination/ 
dehydrobromination reactions on all but the methyl ether 
was almost certainly related to the stability of the
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protecting groups to pH. The silyl and ester protected 
compounds are not stable to strong base and so the groups 
would have been cleaved during the dehydrobromination 
step leaving the reactive alkoxide. Acid work-up of this 
crude mixture could lead to isolation of the alcohol 
which would be of great use later in the reaction scheme. 
Unfortunately due to a lack of time it was not possible 
to investigate this idea further.
Due to the setbacks encountered in the production of 
a suitably protected allylic alcohol (36) by the modified 
Paulsen and MaaB approach an entirely different method 
for its synthesis was evaluated (scheme 26).
Cyclopentanone was employed as a cheap and readily
available starting material. A single bromination alpha
to the ketone was achieved by the use of cupric bromide
( 92 }in chloroform/ethyl acetate (1:1 mixture)' ' and the 
oL -bromoketone produced was then used in its crude state
for the next step which involved the displacement of the
. — •+bromine by nucleophilic attack of a phenylthio (PhS Na )
functionality. The et -phenylthioketone (70) was thus 
isolated in 73% yield as a clear, colourless, pungent 
oil. Confirmation of the product as the desired 
structure was undertaken by 1H NMR analysis. The 
spectrum contained the indicative multiplet signal at 
7.15 ppm correlating to the 5 aromatic hydrogens, also
-108-
the multiplet signal for the single hydrogen alpha to the
Scheme 26 
0
(iii)
•S (0) Ph
(72)
(iv)
(v)
S (O) Ph
(71)
PhCH2OCH2 (vi) hoch2^ A ^
(vii)
OH
HO'
(36)
Reagents: (i) CuBr2/ CHC13/ EtOAc, (ii) PhS Ha
(iii) NalO , (iv) a) LDA, b) PhCH_OCH_Cl, (v) heat
(vi) [H], (vii) [hydride]
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carbonyl and phenylthio had shifted as would be expected 
from 4.15 ppm for the bromoketone to 3.50 ppm. Reaction 
of this phenylthio (70) with NalO^93  ^ (1 mole 
equivalent) gave the sulphoxide derivative (71) as a pale 
yellow solid (81%). This reaction was easily monitored 
by TLC due to the dramatic drop in Rf for the sulphoxide 
product as compared with the sulphide starting material. 
The reason for synthesizing the sulphoxide was so that at 
a later point the double bond functionality could be 
inserted into the ring by thermal elimination of the 
suphoxide group which followed by reduction of the ketone 
would produce an allylic alcohol of the desired type.
The next step in the synthesis was crucial to the overall
production of the allylic alcohol (36). Grieco and
. ( 94 )Pogonowskiv ' had used the sulphoxide (71) to produce 
compounds with a functionality alpha to the ketone but on 
the opposite side to the sulphoxide. This was achieved 
by synthesizing the dianion using LDA and reacting this 
nucleophile with a suitable electrophilic reagent. 
Employing this methodology it was thought that 
substitution of a benzyl chloromethyl ether for the 
chlorobenzene employed by Grieco could lead to the 
interesting compound (72) (scheme 26) which would contain 
both a benzyl protected alcohol and a ketone 
functionality. These groups in combination with the 
sulphoxide would give a compound which contains all the 
functionalities desired for the production of the allylic
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alcohol required. Numerous attempts at this reaction led 
only to recovered starting materials and a few minor 
unknown products.
Due to the great length of time spent on optimizing 
the bromination/dehydrobromination reaction and the 
failure of the new possible scheme (scheme 26) it was 
decided to continue along the initial reaction pathway 
(schemes 21/22) using the methyl ether (6 8). The crude 
allylic ketal methyl ether (69) was taken and the ketal 
deprotected by stirring in a mixture of coarse silica and 
oxalic acid. Column chromatography yielded the cC,B- 
unsaturated ketone (65) in 93% yield. The IR spectrum 
suggested that the reaction had proceeded as expected by 
the appearance of a peak at 1710 cm”1 which could 
correlate for the ketone carbonyl. This was further 
confirmed by the disappearance of the singlet for the 
ethylene ketal protecting group at 3.96 ppm in the proton 
NMR. Efforts to then deprotect the methyl ether 
following Paulsen and MaaB' methodology using TMSI proved 
unsuccessful with complex mixtures being recovered. 
Further attempts at ether deprotection employing 
TMSCl/Nal^88  ^ and 6-bromocatecholborane^89  ^ led to the 
recovery of starting materials only.
Pressing ahead with the methyl protected ot ,B- 
unsaturated ketone, the next step was the reduction of
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the ketone to the secondary alcohol (36). This would 
produce the allylic alcohol functionality required for 
the Claisen and aza-Claisen rearrangements. The methyl 
ether was probably not going to be a bulky enough group 
to direct the reduction in the way desired and initial 
reductions with LiAlH4 at low temperatures (<-20°C) 
yielded the allylic alcohol (36) as the two epimers in 
roughly equal amounts which could be separated by column 
chromatography (97/3 chloroform/methanol).
In order to determine which of the two products isolated 
by the chromatography was the desired cis, 6 isomer it 
was necessary to perform some NOE NMR experiments. NOE 
and 2D-C0SY spectra were also analysed to determine 
whether any Ferrier type rearrangements had occurred.
For the product with the higher Rf value, NOE's were 
observed between and CH-1. This established the
position of this methylene group as being adjacent to the 
double bond and thus no Ferrier rearrangement had 
occurred. Irradiation of H3 gave enhancement of H4 by
H OH
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approximately 3% and conversely irradiation of H4 
enhanced the signal for H3. This result established that 
H3 and H4 were on the same face of the ring and therefore 
this product was the desired cis-(B)-epimer. To further 
confirm this result NOE and 2D-C0SY experiments were 
performed on the product with the lower Rf. 2D-C0SY 
confirmed that CH^-S were coupled to a double bond proton 
whereas H4 was not. This again confirmed that no Ferrier 
type rearrangement had arisen. NOE was observed between 
CH2~6 and H3 (approx. 1.6%) but not between H4 and H3. 
This confirms that H4 and H3 are on opposite faces of the 
ring and therefore this product was the trans-(alpha)- 
epimer.
NMR (360 MHz/30°C) also verified the presence of a 
contaminant in the sample of the B-epimer which was found 
to be a by-product of the LiAlH^ reduction of the ©C ,B- 
unsaturated ketone. Even at the low temperatures 
employed (<-20°C) reduction of the ketone was accompanied 
by saturation of the double bond leading to the fully 
saturated alcohol (73) which was the contaminant 
observed.
HO
(73)
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Lowering the reaction temperature and use of 
stoichemetrically correct amounts of LiAlH^ although 
slightly lessening the degree of saturation did not fully 
prevent it. Even the best conditions led to 
approximately 10% saturation and this product was 
inseparable, by chromatography, from the desired B- 
epimer. A further drawback of this LiAlH^ reduction was 
that no hydride directing effect was witnessed and thus 
alpha and B epimers were isolated in similar yields of 28 
and 30% respectively.
Due to these problems of saturation combined with 
poor yield of the desired B-epimer the use of other 
reducing agents was assessed. An obvious choice due to 
its selectivity for the ketone (leaving the double bond 
unaffected) and steric bulkiness was di-isobutylaluminium 
hydride (DIBAL)^90 .^ Reaction of the purified 
unsaturated ketone (65) in toluene with 1.5 equivalents 
of DIBAL (1.0 M in hexanes) at -78°C supplied the alcohol 
as a mixture of epimers in 78% yield. Column 
chromatography again allowed separation of the epimers 
giving a yield of 65% for the B-epimer and 13% for the 
alpha-epimer and subsequent 1H NMR analysis of the B- 
epimer sample showed there to be no saturation of the 
double bond. DIBAL had proven not only to prevent 
saturation but also the reduction had been directed in 
favour of the required B-epimer due to the bulkiness of
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the reducing agent. The use of DIBAL did however have 
drawbacks which included its relatively high price, the 
necessity for low temperatures and its difficulty of use 
on a large scale. This latter difficulty revolved around 
the work-up procedure of such reactions. After quenching 
with water and methanol, a thick gelatinous mixture was 
produced which could be filtered only with difficulty 
even when hyflo filter aid was employed. In an attempt 
to obtain the maximum yield an inordinate length of time 
was required to wash the filter cake thoroughly even on a 
small scale.
The reducing agent of choice for these ct , B-
unsaturated ketone systems within a ring is now NaBH^ and
(90 91^CeCl3 in methanolk ' . This reagent is highly
selective for ketones at its operating temperature of 
0°C, producing very little (<3%) saturation and when used 
in conjunction with the oC , B-unsaturated ketone (65) 
and following purification, the B-epimer was isolated in 
56% and the oL-epimer in 24% yield. NMR verified
that very little (<3%) of the saturated by-product had 
been generated. Although the use of NaBH^ and CeCl3 does 
not deliver as good a ratio of B to oL epimers as DIBAL 
this disadvantage is overcome by its ease of use on a 
large scale and its low cost. Following the extensive 
use of the NaBH4/CeCl3 reduction on the unsaturated 
ketone (65) it was possible to acquire reasonable 
quantities of the carbocyclic allylic alcohol (36) for
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reaction in Claisen and aza-Claisen rearrangements.
3.3 CLAISEN REARRANGEMENTS
3.3.1 Synthesis and Use of Products
The initial reaction performed on the carbocyclic
alcohol (36) was an amide-acetal Claisen rearrangement
employing dimethylacetamide dimethylacetal in refluxing
o-xylene to furnish the rearranged amide (74) as a clear,
pale yellow, viscous liquid in 74% yield (Figure 28).
Confirmation of the rearranged amide structure was
established by spectral data. The appearance of the C=0
-1 .peak at 1649 cm m  the IR spectrum for the amide 
carbonyl and the shift of the olefin signals in the 
proton NMR spectrum to 5.80 ppm were both indicative of 
the desired product. The appearance in the proton NMR of 
the singlets at 2.95 and 3.00 ppm correlating for the 
amide methyl groups was further positive evidence that 
the correct product had been synthesized.
This amide although possibly quite useful as a 
precursor in the synthesis of carbocyclic C-nucleosides 
was not as immediately interesting as the ester product 
from the Johnson type Claisen rearrangement. Because the
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Figure 28
(74)OH
Reagents: (i) CH3C(OCH3 )2N(CH3)2/ o-xylene/ reflux
molecular framework of the allylic alcohol is now based 
upon the cyclopentane ring the acid catalyzed Ferrier 
rearrangement is no longer a concern. The reaction of 
allylic alcohol (36) and trimethyl orthoacetate using 
propionic acid as catalyst was thus attempted (Scheme 27) 
and following 24 hours reflux it was found that the 
rearrangement had worked well producing, after 
purification, the ester (75) in 76% yield. Once again 
the IR spectrum was extremely useful in establishing the 
generation of the ester (75) by the appearance of the 
indicative carbonyl C=0 peak at 1756 cm"1. FAB-MS also 
aided in the confirmation of the structure by the 
identification of the MH+ signal at 185 mass units. 
Reaction of this ester (75) with ethyl formate and sodium 
hydride generated the cC t 6-unsaturated ester (76) in 
poor yield (<10%). Reaction of this ester with base and 
guanidine should in a single step deliver a carbocyclic 
C-nucleoside analogue. If this ring closure reaction
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worked the previous step would have to be optimized to 
produce far better yields of the unsaturated ester (76) 
but unfortunately due to the lack of time it was not 
possible to investigate this further.
Scheme 27
(i)
OH (75)
c h 3o
co2ch3
(76)
Reagents: (i)MeC(OMe)3/ propionic acid/ reflux
(ii) a) NaH/ EtOH/ HCOOEt, b) Mel
3.4 AZA-CLAISEN REARRANGEMENTS
3.4.1 Synthesis and Use of Products
Preliminary reactions on the carbocyclic allylic 
alcohol (36) using sodium hydrdide, trichloroacetonitrile 
and sodium dried ether were inconclusive with on 
occasions some product appearing to be formed yet on
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others none being witnessed by IR and TLC analysis. The 
use of ether dried over LiAlH., distilled trichloro- 
acetonitrile and flame dried equipment solved this 
problem. Reaction of the alcohol (36) with 0.1 
equivalents of sodium hydride in LiAlH4 dried ether and 
subsequent addition to distilled trichloroacetonitrile at 
0°C yielded the trichloroacetimidate intermediate.
Unlike the furan system the rearrangement of this imidate 
to the acetamide was not facile under these reaction 
conditions and it was necessary to effect the 
rearrangement in refluxing toluene over a period of up to 
8 hours (Scheme 28). The intermediate imidate (77) was 
water sensitive and was therefore used without further 
purification for the thermal rearrangement to furnish the 
crude trichloroacetamide as an orange liquid. Column 
chromatography permitted isolation of the 
trichloroacetamide as a pure white solid in good yield 
(68%) whose structure was confirmed by spectral data. An 
IR spectrum established the presence of a peak for N-H 
str. at 3340 cm”1 and for C=0 str. at 1730 cm”1. 1H NMR 
further confirmed the presence of the amide by the broad 
singlet at 7.45 ppm for the amide hydrogen and by a shift 
in the olefinic signal to 5.7 ppm as would be expected. 
Agreement between the theoretical and experimentally 
achieved values for the micro-analysis of the product was 
the final piece of concurring evidence required to prove 
the white crystalline solid was the desired
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trichloroacetamide (78). This product (78) would appear 
to be an excellent precursor for the synthesis of 
carbocyclic nucleosides as hydrolysis of the trichloro­
acetamide group to the amine would leave a compound onto 
which heterocyclic bases could easily be built.
Scheme 28
(i)
OH OC— CC13IINH
(77)J'1'
(78)
Reagents: (i) NaH/ Cl3CCNf (ii) toluene/ reflux
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3.4.2 Use of Trichloroacetamide (78) in the Production 
of Nucleoside Analogues
Overmann's method for the hydrolysis of the
trichloroacetamide to the free amine employed 2N NaOH in
ethanol at room temperature but in this case the amide
(78) reacted to yield a baseline product, by TLC, which
was both difficult to work-up and isolate. Fortunately
however as there are no longer any acid labile
fuunctionalities in the molecule it was possible to
hydrolyse the amide (78) in refluxing 2N HC1 (scheme 29).
This hydrolysis furnished the amine hydrochloride which
was used immediately without purification in the next
stage of the synthesis. It was this production of the
amine hydrochloride that at last gave us an introduction
to a variety of reactions which would lead to the
formation of purine and pyrimidine bases. The quickest
and easiest route to a number of carbocyclic nucleoside
analogues appeared to be with the use of a
dichloropyrimidine derivative. This methodology would
create a series of purine nucleoside analogues and has
(43}been employed by Roberts et alv ' who made use of 2- 
amino-4,6-dichloropyrimidine in the production of 
carbovir (Scheme 29).
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HO. +^  NH3 Cl
u
(i)
HO,
(ii)
Cl
cic6h4n==^nn J ^ n
i' ^ ^ n ^ Nvn h -HN'
(iii)
HO.
H2N.
H n 'nh2
(iv)
(79)
HO
(81) 
Reagents:
<xx
(i) 2-amino-4,6-dichloropyrimidine / base(ii) 4-C1C H N  Cl", (iii) Zn/ HOAc,(iv) (EtO)3CH/ HC1, (v) NaOH/ reflux
- 122-
As can be seen the use of 2-amino-4,6- 
dichloropyrimidine to produce (83) necessitates the 
formation of an amine functionality at carbon 5 via means 
of a diazotization followed by reduction with zinc-acetic 
acid and it is this amine which is vital for ring closure 
of the pentacyclic ring forming the purine structure. A 
quicker route to a series of nucleoside analogues would 
appear to be by substituting the 2-aminopyrimidine with a 
5-amino derivative. Obviously carbovir and its analogues 
would now no longer be initially synthesized due to the 
lack of an amine functionality at C-2 but an array of
other nucleoside analogues would be possible. Lim and
(3 8 }Marquez1 ' had previously made use of this 5-amino-4,6-
dichloropyrimidine during their synthesis of neplanocin 
A.
The trichloroacetamide (78) was thus hydrolysed in 
refluxing 2N HC1 and ethanol to generate the desired 
amine hydrochloride and this product was immediately 
refluxed in a mixture of n-butanol, diisopropylethylamine 
and 5-amino-4,6-dichloropyrimidine (2 mole equivalents) 
for 48 hours to deliver the diamine (79) as white needles 
(61%) with a melting point of 114-116°. The peaks at 
3000-3500 cm-1 and 1630/1590 cnT1 in the IR spectrum of 
this compound (79) corresponded for the amine and C=C/C=N 
functionalities expected. The molecular ions at 254 and 
256 witnessed in the EI-MS of this product established 
the presence of chlorine as expected. Subsequent
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reaction of this diamine (79) with freshly distilled 
triethyl orthoformate and concentrated HC1 at room 
temperature for 24 hours furnished the ring closed 
chloropurine analogue (80) whose IR spectrum showed a 
loss of any amine peaks between 3000 and 3500 cm-1, thus 
confirming reaction had taken place. Column 
chromatography yielded (80) as an off-white solid (80%) 
(Scheme 30).
The diamine (79) could also be used in the production 
of the triazole compound^80  ^ as shown in figure 29. 
Synthesis of this compound was accomplished by reaction 
of (79) with sodium nitrite in an acetic acid/ water 
mixture at 0°C and it appeared as a pale brown solid 
(73%) whose structure was confirmed by IR and H NMR 
data.
From the chloropurine (80) synthesis of both 
adenosine and inosine purine nucleoside analogues was 
possible. Hydrolysis of (80) in gently refluxing 0.3N 
NaOH yielded, after purification, the dideoxyinosine 
analogue (81) as an off white solid (66%) (Figure 30) 
whose structure was confirmed by IR, NMR and HRMS. A 
particularly characteristic feature of the product was 
the combination of -OH and C=0 stretching frequencies in 
the IR spectrum, relating to the two isomers.
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Scheme 30
CH30.
\
NHC(O)CCI3 (i)
CH3O. + _ NH3 CI
\
(ii)
Cl
Cl
N
«N
(iii)
Reagents: (i) H / EtOH, (ii) 5-amino-4,6-dichloropyrim-
idine/ *Pr2NEt/ butanol/ reflux, (iii) (EtO)3CH/ HC1 
then HCl/ H2Q
To obtain an adenosine nucleoside analogue it was 
necessary to react the chloropurine (80) in a closed 
system with a 2:1 mixture of concentrated ammonia and 
methanol. 48 hours at 60°C was followed by purification 
using rapid micro-column chromatography to furnish the
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Figure 29
Cl Cl
h2n.
(79) (84)
Reagents: (i) AcOH/ HaNO^
Cl
Figure 30
(i)
81)
OH
Reagents: (i) HaOH/ H20/ reflux
dideoxyadenosine compound (82) (Figure 31) in 60% yield 
whose IR spectrum showed the expected reappearance of N-H
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_ 1peaks between 3000 and 3500 cm
Figure 31
Cl NH2
c h 3o
(i) >
ch3o,
(82)
Reagents: (i) NH3 (cone)/ EtOH
As can be seen therefore a range of carbocyclic 
nucleoside analogues have been produced which during 
their linear synthesis have undergone an aza-Claisen 
rearrangement to gain the correct relative 
stereochemistry for heterocyclic base build up. All the 
nucleosides produced so far have been in racemic form 
only.
3.5 SUMMARY AND FUTURE WORK
The allylic alcohol (36) was produced in a 6 step 
synthesis from 2-oxocyclopentanecarboxylate ethyl ester. 
The desired B-epimer of the alcohol (36) was isolated and 
its structure confirmed by NOE NMR experimentation.
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Further work is however needed in the bromination/ 
dehydrobromination stage so that protecting groups more 
useful than the methyl ether could be used. This will 
mean a more thorough examination of the use of pyridinium 
hydrobromide perbromide and trimethylammonium tribromide 
as brominating agents in THF. The protecting group 
decided upon must be stable to the strong bases employed 
in the dehydrobromination step. This could mean further 
evaluation of the trityl and monomethoxymethyl ether 
protecting groups.
The Claisen rearrangements on the allylic alcohol 
(36) employing amide-acetals and trimethyl orthoacetate 
both worked well. The amide functionality has not yet 
been fully evaluated for its use as a precursor to 
carbocyclic C-nucleosides. The ester rearranged compound 
(75) shows much promise as an intermediate to 
C-nucleosides. Optimization of the ethyl formate 
reaction to yield the unsaturated ester (76) and 
subsequent successful reaction of this product with 
guanidine should produce a carbocyclic C-nucleoside 
analogue.
The aza-Claisen rearrangement on the alcohol (36) was 
very water sensitive and all reagents and solvents were 
scrupulously dried before their use. The overall yield 
of the rearrangement was good. The use of the
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trichloroacetamide (78) has led to the successful 
synthesis of a number of carbocyclic dideoxy nucleoside 
analogues in their methyl ether protected form. For 
these compounds to exhibit biological activity it is 
almost certain that a method for removing the methyl 
ether must be found. As has already been stated the 
nucleoside analogues produced have been racemic.
Following biological testing on the racemates it would be 
necessary to produce optically active species of any 
compounds which exhibited any biological activity. This 
would entail the use of the enzymatic or chemical methods 
employed for separating chiral forms discussed earlier 
during the introduction to this thesis.
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4.1. Materials and Techniques
Infrared spectra were obtained on a Pye-Unicam SP3-100 
spectrophotometer. 1H nmr spectra were recorded on Bruker 250 
MHz, Bruker 200 MHz, Bruker WP80 SY and JEOL PMX 60 SI 
spectrometers. Samples were prepared in the solvent stated in 
each method. Microanalyses were determined at the Wellcome 
Foundation, Beckenham. Melting points were determined on an 
Electrothermal melting point apparatus and are uncorrected. Mass 
spectra were recorded at both the Wellcome Foundation and 
Sheffield Hallam University.
IR data is given in cm”1. *H NMR data is given on the ppm 
scale using tetramethylsilane as the internal reference. 
Abbreviations used for the form of the signal are as follows ? 
s = singlet, d = doublet, t = triplet, q = quartet, quin = 
quintet, m = multiplet.
Flash chromatography and column chromatography were performed 
on Merck 7734 and Merck 7730 silica gel respectively. Thin layer 
chromatography was performed on Merck 5554 Alufolien Kieselgel 
60F254 plates.
When required anhydrous solvents were prepared according to
/ gg \literature^ '. All reactions requiring inert atmospheres were 
performed under nitrogen.
-132-
2,3:5,6-Di-O-isopropylidene-B-D-mannofuranose^ 53 ^ (41)
\ h (OH) —  ---■ >
o
0 ‘OH
o o
(41)
To a solution of concentrated H2S04 (3.8 ml) in acetone 
(250 ml) was added anhydrous D-mannose (5.50 g, 30.6 
mmol). Stirring was commenced and continued with the 
exclusion of water for 5 hours. The solution was then 
neutralised by the addition of Na2C03, filtered and the 
residue washed with hot acetone (100 ml). The combined 
extracts were then concentrated and the resultant residue 
was dissolved in dry ether, filtered and precipitated 
with petrol (3 times volume of ether). The precipitate 
was isolated and the mother liquor partially evaporated 
to yield a further portion of product. The combined 
product portions were recrystallized from petrol to yield 
pure (41) (6.72 g, 84.6%).
m.p. : 122-124 °C Lit. M.p. : 121-122°C
IR (KBr): 3005-3580 (OH str), 2980, 2930, 2890 (CH str)
XH NMR : 1.36-1.46 (s+d, 12H), 3.70 (m, 1H), 4.06-4.90
(m, 6H), 5.27 (s, 1H).
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2,3:5,6-Di-O-isopropylidene-S-D-mannofuranosyl
chloride^53^(41a)
0
x °
OH > Cl
(41) (4ia)
To a slurry of (40) (20.0 g, 76.9 mmol) in dry CCl^
(100 ml) was added triphenylphosphine (20.3 g, 76.9 
mmol). The reaction mixture was then heated under reflux 
with the exclusion of water for 14 hours. To the 
solution was added anhydrous lead carbonate (2.0 g) and 
powdered activated charcoal (1.0 g). The resultant 
cooled mixture was filtered (hyflo) and the filter cake 
washed with ice cold CC14 (30 ml). The filtrate was 
concentrated to approximately one third its volume 
whereupon it was cooled in ice and a further portion of 
triphenylphosphine oxide precipitated out. After a 
second filtration (hyflo), the filter cake was washed 
with ice cold petrol (20 ml) and the filtrate 
concentrated to yield crude (41a) as a bright orange, 
clear, viscous liquid. Column chromatography (CH2C12) 
yielded pure (41a) as a clear, pale orange, viscous 
liquid (15.1 g, 70.4%).
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IR (liquid film): 2990, 2940, 2880 (CH str)
XH NMR (CDC13) : 1.25-1.55 (s+d, 12H), 3.95-5.05 (m, 
6H), 5.98 (S, 1H)
MS (El) m/z MH+ 288, MH++2 290
1 ,4-Anhydro-2-deoxy-5,6-o-isopropylidene-D-arabino-hex-
(4la)
To a flame dried flask fitted with a flushing dry 
nitrogen stream, dry ice condenser and seated in a
anhydrous liquid ammonia (500 ml). To this was added 
lithium wire (2.78 g, 0.38 mol) and the clear colourless 
liquid turned opaque navy blue. A solution of furanosyl 
chloride (41a) (18.0 g, 0.065 mol) in dry THF (100 ml) 
was added dropwise, slowly. The cooling bath was then 
removed and ammonia reflux allowed for 2\ hours. 
Anhydrous ammonium chloride (31.2 g, 0.58 mol) was added 
cautiously and the solution changed to a milk-white
l-enitol(4 9)(35)
cooling bath (-78 °C, dry ice/ acetone) was added
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emulsion. This mixture was diluted with ether (400 ml) 
and transferred to a large conical flask using more ether 
(200 ml). After standing for 18 hours the resulting 
ethereal solution was filtered through hyflo filter aid. 
The filter cake was thoroughly washed with ether (300 ml) 
and the combined filtrates were concentrated to yield a 
clear pale green liquid (12.2 g). Column chromatography 
(60/40? petrol/ethyl acetate + 2% Et3N) yielded the pure 
glycal (35) as a clear colourless liquid (9.43 g, 78%).
IR (liquid film): 3200-3550 (OH str), 1640-1680 (C=C str) 
2H NMR (CDC13) : 1.35 (s, 3H), 1.45 (s, 3H), 2.45 (s,
1H) 3.85-4.60 (m, 4H), 4.9 (m, 1H), 5.15 (m, 1H olefin),
6.5 (m, 1H olefin)
MS (El) m/z: MH+ 187.
bis-Phenylthioacetic acid (48)
Cl2CH2C02Et --------------- > (PhS)2CHC02H
Metallic sodium (4.6 g, 0.20 mol) was dissolved in 
dry ethanol (200 ml) and thiophenol (23.2 g, 0.20 mol) 
was added dropwise. After stirring for 30 minutes a
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was added dropwise. After stirring for 30 minutes a 
solution of ethyl dichloroacetate (15.7 g, 0.10 mol) in 
dry ethanol (25 ml) was added, slowly, and the mixture 
left stirring for 14 hours. The ethanol was removed 
along with any residual thiophenol by distillation. The 
resultant cooled mixture was partitioned between ether 
(50 ml) and water (100 ml). The ether layer was the re­
extracted with water (2 x 25 ml), dried (MgSO^) and 
concentrated to yield the crude ester as a clear, 
colourless liquid (23.9 g, 79%).
This crude ester was dissolved in ethanol (100 ml) 
and to this mixture was added a slight excess of an 
aqueous solution of sodium hydroxide (3.4 g in 25 ml 
water). After 4 hours stirring the majority of the 
ethanol was removed, water (75 ml) was added and the 
mixture extracted with ether (2 x 20 ml). The aqueous 
layer was then acidified (approx. pH 2) with conc. HC1 
and the white crystalline product formed was filtered 
off, washed with water and dried in vacuo yielding 
(20.9 g, 96%) of the carboxylic acid (48).
IR (KBr disc) : 2500-3300 (OH str), 1690-1730 (C=0 str),
1590,1480 (C=C str)
H NMR (CDC13): 4.66 (s, 1H), 5.95 (s,br, 1H), 7.1 (m,
10H)
MS (El) m/z: M+ 276
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bis-Phenylthioacetyl chloride (49)
(PhS)2CHC02H --------------- > (PhS)2CHC(0)Cl
To a stirred solution of the acid (48) (4.0 g, 14 
mmol) in dry dichloromethane (80 ml) at 0°C under 
nitrogen was added dry DMF (0.13 ml) and oxalyl chloride 
(3.8 g, 30 mmol). The reaction was stirred for 14 hours 
and then concentrated to furnish the crude acid chloride 
(49) as a dark orange oil (4.10 g). Column 
chromatography yielded pure (49) as a clear yellow oil 
(3.55 g, 86%).
IR (liquid film): 3060 (CH str), 1750-1820 (C=0 str)
1580, 1490 (C=C str).
XH NMR (CDC13) : 4.85 (s, 1H), 7.2 (m, 10H).
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Attempted Preparation of 2 ,5-dihydro-5-(2 ,2-dimethyl-l,3- 
dioxolan-4-yl)- oL, cL , bisphenylthiofuran-2-acetic acid 
from (35)
)
X uC(SC6H5)2C02H
HO (35)
To a stirred solution of starting alcohol (35) (720 
mg, 3.87 mmol) in dry THF (10 ml) at -78°C (dry ice/ 
acetone) under nitrogen was added n-butyllithium (1.6 M 
in hexanes) (2.4 ml. 3.90 mmol). After stirring for 15 
minutes a solution of the acid chloride (49) (1.08 g,
3.90 mmol) in dry THF (5 ml) was added. After 5 minutes 
at 0°C the mixture was added dropwise to a stirred 
solution of LDA (7.8 mmol) in dry THF (10 ml) at -78°C. 
Ten minutes later the reaction was treated with 
trimethylsilyl chloride (7.8 mmol) and the reaction 
allowed to warm to room temperature and stir for a 
further 1 hour. The mixture was then diluted with 0.5N 
NaOH (40 ml) and washed with ether (5 ml). The aqueous 
layer was acidified (pH 2) and extracted with ether (4 x 
20 ml). The combined organics were dried (MgSC>4 ) and 
concentrated to yield a complex mixture of products. 
Isolation of these components by column chromatography
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(50/50? petrol/ethyl acetate) showed that the desired 
product had not been formed.
2,5-Dihydro-5-(2,2-dimethyl-l,3-dioxolan-4-yl)-methoxy 
furan N ,N-dimethyacetamide (51)
P y/  0‘ C (0) N (CH3) 2HO (35) (51)
A flame dried flask was charged with the alcohol (35) 
(1.00 g , 5.4 mmol), dimethylacetamide dimethylacetal 
(3.60 g, 27 mmol) and o-xylene (20 ml). The mixture was 
refluxed under a positive pressure of nitrogen for 48 
hours. The solution was then concentrated to yield the 
crude amide (51) as a dark brown oil (1.45 g). Column 
chromatography (50/50? petrol/ethyl acetate + 2% Et3N) 
provided the pure amide (51) as a clear colourless gum 
(980 mg, 71%).
FT-IR (liquid film): 2989, 2935, 2905, 2881, 1639 (C=0
str), 1067
XH NMR-250 MHz (CDC13): 1.35 (s, 3H), 1.45 (s, 3H),
2.35-2.80 (m, 2H), 2.95 (s, 2H), 3.05 (s, 3H), 3.95 (m,
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3H), 4.65 (m, 1H), 5.20 (m, 1H), 5.95 (m, 1H olefin),
6.08 (m, 1H olefin).
MS (El + FAB) m/z: M-H+ 256
Microanalysis found: C, 60.81? H, 8.12? N, 5.27?
5-(2,2-dimethy1-1,3-dioxolan-4-yl)-methoxyfuran N , N- 
dimethylacetamide (52)
To the amide (51) (500 mg, 1.96 mmol) in ethanol (5 
ml) and triethylamine (1 ml) was added Adams catalyst 
(PtO) (25 mg) and the reaction was placed under a 
positive pressure of hydrogen. The catalyst was filtered 
off and the filter cake washed with ethanol. The 
combined filtrates were concentrated and the product 
appeared as a clear pale yellow syrup (420 mg, 84%).
IR (liquid film): 2980, 2920, 2880,1670 (C=0 str)
NMR (CDC13): 1.2-1.5 (m, 7H), 1.8-2.2 (m, 3H), 2.4-
2.75 (m, 2H), 3.0 (m, 6H), 3.75-4.25 (m, 5H).
C13H21N04 : c » 61.16? H, 8.29? N, 5.49
>
(51) (52)
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Attempted Preparation of 2,5-dihydro-5-(2,2-dimethyl-l,3 
dioxolan-4-yl)-methoxyfuran acetic acid from (35)
To a flame dried flask was added the alcohol (35) 
(1.00 g, 5.4 mmol) and dry ether (15 ml). After cooling
after which time a solution of acetyl chloride (460 mg,
5.9 mmol) in dry ether (5 ml) was added dropwise. The 
cooling bath was removed and stirring continued for 5 
hours. The mixture was poured into iced water (50 ml) 
and the ether separated. The aqueous layer was extracted 
with ether (4 X 15 ml) and the combined organics were 
washed with water (2 X 15 ml), dried (MgS04) and 
concentrated. This reaction supplied only recovery of 
starting materials and one minor unknown product.
HO (35) OCOCH3
to 0°C n-butyllithium (3.6 ml, 5.7 mmol) was added 
dropwise. The reaction was stirred at 0°C for 1 hour
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2 ,5-Dihydro-5-(2 ,2-dimethyl-l,3-dioxolan-4-yl)-fur an 
trichloroacetamide (53)
HO (53)
(35)
To sodium hydride (215 mg, 5.4 mmol) was added petrol 
(10 ml) and the oil removed with a pipette. The hydride 
was then suspended in dry ether (20 ml). To this was 
added, dropwise, a solution of the alcohol (35) (10.0 g, 
54 mmol) in dry ether (20 ml). Stirring was continued 
for 30 minutes after which time hydrogen evolution had 
ceased. After cooling to 0°C a solution of 
trichloroacetonitrile (7.8 g, 54 mmol) in dry ether (20 
ml) was added dropwise. This mixture was left for 3 
hours whereupon the solvents were removed under reduced 
pressure. A solution of petrol (40 ml) containing 0.1% 
methanol was added and the mixture shaken vigorously for 
1 minute. The resultant solution was filtered by gravity 
and the process was then repeated twice more. The 
combined filtrates were concentrated to supply crude (53) 
as a soft yellow solid (15.9 g). Recrystallization from 
petrol furnished pure trichloroacetamide (53) as a white 
crystalline solid (13.9 g, 78 %).
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IR (KBr disc): 3320, 3380 (NH str), 1720 (C=0 str)
NMR—250 MH2 (CDC13): 1.35 (s, 3H), 1.42 (s, 3H), 3.8
(q, 1H), 4.1 (q, 1H), 4.35 (m, 1H), 4.75 (m, 1H), 6.0 (m, 
1H), 6.15 (m, 1H), 6.45 (m, 1H), 7.6 (s,br, 1H).
MS (FAB) m/z: MH+ 330, MH+ (37C1) 332,
MH+ (-NHC0CC13) 169
Microanalysis found : C, 40.24; H, 4.31; N, 4.03
C, -.H- .CloN0requires: C, 39.98; H, 4.27; N, 4.24 11 14 J 4
2,5-Dihydro-5-(2,2-dimethyl-l,3-dioxolan-4-yl) 
furan acetamide (55)
0
NHC0 CC1
(53)
NHC
S \ )  nch3
(55)
To the trichloroacetamide (53) (1.00 g, 3.03 mmol) in 
ethyl acetate (8 ml) and triethylamine (2 ml) was added 
Adams catalyst (PtO) (50 mg) and the mixture was 
hydrogenated at room temperature and just above 
atmospheric pressure. Upon completion of reaction the 
catalyst was filtered off and the solvent removed under 
reduced pressure. The product appeared as an orange 
syrup (620 mg, 89%).
-144-
IR (Liquid Film): 3260-3500 (N-H str), 2990, 2960, 2900,
1680 (C=0 str)
XH NMR (CDC13): 1.1-1.7 (m, 4H), 1.4 (s, 3H), 1.5 (s,
3H), 1.95 (s, 3H), 3.8-4.1 (m, 4H), 5.6 (m, 1H)
7.1 (s, br, 1H)
Ethyl 1,4-dioxaspiro [4.4] nonane-6-carboxylate ^50 ^ (64)
0
^ ^ - 0 0 2  Et
(63)
To dry benzene (500 ml) was added ethyl 2-oxocyclopen 
tanecarboxylate (50.0 g, 0.32 mol), ethylene glycol (49.5 
g, 0.80 mol) and p-toluenesulphonic acid (1.5 g, 8.0 
mmol). The mixture was refluxed under a Dean-Stark trap 
with the strict exclusion of water for 48 hours. After 
cooling to room temperature the sample was washed with 2N 
NaOH (2 x 120 ml) and water (3 x 50 ml), dried (MgS04) 
and concentrated to yield a very pale green liquid.
Column chromatography (80/20; petrol/ethyl acetate) gave 
(64) as a clear colourless liquid (48.4 g,
75.6%).
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IR (Liquid film): 1725 (C=0 str)
XH NMR (CDC13): 1.30 (t, 3H J = 7.1Hz)), 1.60-2.30 (m,
6H), 2.30-
2.45 (m, 1H), 3.98 (s, 4H), 4.1 (q, 2H)
1,4-Dioxaspiro [4.4] non-6-ylmethanol (66)
■C02Et
(64)
•CH2OH
(66)
To a suspension of LiAlH4 (9.1 g, 0.24 mol) in dry
ether (300 ml) at 0° was added, dropwise, a solution of
(64) (48.4 g, 0.24 mol) in dry ether (200 ml). The
solution was stirred for two hours at 0° and for a
further 14 hours at room temperature. 15% NaOH in
saturated Na.SO. (24.8 ml) was added with caution to the 2 4
ice cooled mixture. The mixture was then filtered and 
the filter cake washed with ether (500 ml) and the 
combined ether layers were dried (MgSO^) and concentrated 
to yield (66) as a clear colourless liquid (36.8 g, 97%) 
which required no further purification.
IR (Liquid film): 3250-3600 (br, OH str), no C=0 str
1H NMR (CDC13): 1.52-1.98 (m, 6H), 2.04-2.25 (m, 1H) ,
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3.60 (d, 2H, J = 6.2Hz), 3.88 (s, 4H) 
6-Methoxymethyl-lf4-dioxaspiro [4.4] nonane (68a)
OH
(66) (68a)
To sodium hydride (1.8 g, 45 mmol) was added petrol 
(25 ml) and the oil removed with a pipette. The hydride 
was then suspended in dry THF (40 ml) and the alcohol 
(6 6) (7.05 g, 41 mmol) was added dropwise as a solution 
in dry THF (20 ml). After 3 hours at room temperature 
followed by ice cooling methyl iodide (9.1 g, 64 mmol) 
was added slowly, dropwise, and stirring was continued 
for a further 14 hours. After this time iced water (100 
ml) was added and the mixture extracted with ether (4 x 
50 ml). The combined organic layers were dried (MgSO^) 
and concentrated to yield (68a) as a light orange liquid 
(5.3 g). Column chromatography (80/20? petrol/ethyl 
acetate + 2% Et3N) yielded (68a) as a clear colourless 
liquid (4.6 g, 84%).
IR (Liquid film): 2965, 2920, 2890 (CH str), 1120 (CH b)
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^  NMR (CDC1 ) : 1.39-1.99 (Bl, 6H), 2.22 (m, 1H), 3.30-
3.50 (m, 2H), 3.35 (S, 3H), 3.91 (s, 4H)
6-Triphenylmethoxymethyl-l,4-dioxaspiro [4.4] 
nonane (68b)
OH
(66) (68b)
To a solution of triphenylmethyl chloride (7.05 g,
25.3 mmol) and DMAP (8 mg) in dry pyridine (20 ml) was 
added a solution of the alcohol (66) (4.3 g, 25.3 mmol) 
in dry pyridine (10 ml). After stirring at room 
temperature for 32 hours the reaction mixture was poured 
into water (100 ml) and the aqueous solution extracted 
with petrol (4 x 20 ml). The combined petrol layers were 
washed with water (4 x 20 ml), dried (MgS04) and 
concentrated to yield crude (68b) as a light green highly 
viscous liquid (9.87 g). Column chromatography (90/10? 
petrol/ethyl acetate + 2% Et3N) gave pure (68b) as a 
clear colourless gum which slowly crystallized in the 
freezer to a pure white solid (7.29 g, 72%).
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IR (KBr disc) : 3060, 3090, 2990, 2960 (CH str)
760, 690 (C-H b)
1H NMR (CDC13): 1.4-2.1 (m, 6H), 2.28 (quin, 1H, J =
&&Hz), 3.1 (m, 2H), 3.75 (m, 4H), 7.3 (m, 15H)
MS (FAB) m/z: H-H+ 399.0, CPh3+ 243.0, CPh2+ 165.0
Microanalysis found: C, 81.05; H, 7.10; O, 11.85
C27H28°3 re^u^res s c ' 80.90; H, 7.05; O, 11.98
6-Benzyloxymethyl-l,4-dioxaspiro [4.4] nonane (68c)
OH
(66) (68c)
To sodium hydride (1.11 g, 28 mmol) was added petrol 
(25 ml) and the oil removed with a pipette. The hydride 
was then suspended in dry THF (40 ml) and the alcohol 
(66) (4.0 g, 25 mmol) was added dropwise as a solution in 
dry THF (10 ml). Following 2\ hours at room temperature 
and 30 minutes at O0 a solution of benzyl bromide (4.33 g 
25 mmol) in dry THF (15 ml) was added dropwise and the 
resulting solution was left stirring at ambient 
temperature for 14 hours. The mixture was then poured 
into iced water (100 ml) and this aqueous solution was
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extracted with ether (5 x 40 ml). The combined organic 
layers were washed with water (2 x 40 ml), brine (40 ml), 
dried (MgS04) and concentrated to yield crude ether (68c) 
as a very pale green liquid. Column chromatography 
(90/10; petrol/ethyl acetate + 2% Et3N) yielded (68c) as 
a clear colourless liquid (6.01 g, 97%).
FT-IR (Liquid film): 2982, 2930, 1450 wk,
1275 strong, 1117, 714 strong, 680, 770 (C-H b)
XH NMR (CDC13): 1.4-2.45 (m, 7H), 3.25-3.6 (m, 2H), 3.75
(s, 4H), 4.4 (s, 2H), 7.15 (s, 5H)
6-Methoxyethoxymethoxymethyl-l,4-dioxaspiro [4.4] 
nonane (68d)
“OH
(66)
0CH20(CH2) 2°CH3
(68d)
To sodium hydride (310 mg, 7.6 mmol) was added petrol 
(5 ml) and the oil was removed with a pipette. The 
hydride was suspended in dry THF (8 ml) and a solution of 
the alcohol (66) (1.00 g, 6.3 mmol) in dry THF (4 ml) was 
added dropwise. After 2\ hours at room temperature and
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30 minutes at 0° a solution of freshly distilled 
methoxyethoxymethyl chloride (950 mg, 7.6 mmol) in dry 
THF (4 ml) was added dropwise. After stirring for 24 
hours the reaction mixture was poured into iced water (30 
ml) and the aqueous layer extracted with ether (5 x 20 
ml). The combined ether portions were dried (MgS04) and 
concentrated to give crude (68d) as a clear colourless 
liquid. Column chromatography (50/50; petrol/ethyl 
acetate + 2% Et3N) yielded pure (68d) as a clear 
colourless liquid (1.27 g, 68%).
IR (Liquid film): 2940, 2920, 2870, 1110, 1040 
1H NMR (CDC13) : 1.45-2.05 (m, 6H), 2.25 (quin, 1H),
3.4 (s, 1H), 3.45-3.75 (m, 6H), 3.90 (s, 4H), 4.7-4.85
(m, 2H)
6-t-Butyldiphenylsilyloxymethyl-l,4-dioxaspiro [4.4] 
nonane (68e)
'OH
(66)
OSi(C6H 5 )2 C(CH3) 3
(68e)
To dry DMF (15 ml) was added t-butyldiphenylsilyl 
chloride (1.91 g, 7.0 mmol), imidazole (0.95 g, 13.9
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mmol) and the alcohol (66) (1.00 g, 6.3 mmol) and 
stirring was continued for 48 hours at room temperature 
with the exclusion of water. The mixture was then poured 
into water (50 ml) and the aqueous phase was extracted 
with petrol (4 x 15 ml). The combined organics were 
washed with water (3 x 10 ml), dried (MgS04) and 
concentrated to yield a pale green gum (3.0 g) which was 
purified by column chromatography (85/15? petrol/ethyl 
acetate + 2% Et^N). The desired silyl ether (68e) 
appeared as a clear colourless gum (2.17 g, 87%).
IR (Liquid film): 3040/3080 wk, 2940, 2860, 1430 wk,
1120 v strong, 780 v strong
XH NMR (CDC13) : 1.05 (s, 9H), 1.40-2.38 (m, 7H), 3.33-
3.85 (m, 2H), 3.75 (s, 3H), 7.15-7.75 (m, 10H)
MS (FAB) m/z : MH+ 396
6-t-Butyldimethylsiloxymethyl-l,4-dioxaspiro [4.4] 
nonane (68f)
‘OSi (CH3) 2C (CH3) 3
(68f)
OH
(66)
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To dry DMF (15 ml) was added the alcohol (6 6) (1.00 g
6.3 mmol), t-butyldimethylsilyl chloride (1.1 g, 7.2 
mmol) and imidazole (0.95 g, 13.9 mmol). After stirring 
for 48 hours at room temperature with the exclusion of 
water the mixture was poured into water (50 ml) and the
aqueous phase was extracted with petrol (4 x 15 ml). The
combined organics were washed with water (3 x 10 ml), 
dried (MgS04) and concentrated to yield (68f) as a pale 
yellow viscous liquid. Column chromatography (85/15; 
petrol/ethyl acetate + 2% Et3N) yielded the pure silyl 
ether as a clear, colourless liquid (1.37 g, 80%).
IR (Liquid film): 2960, 2940, 2870, 2850, 1260,
1120 v strong, 780 v strong
XH NMR (CDC13) : 0.0 (s, 6H), 0.8 (s, 9H), 1.4-2.25 (m,
7H), 3.4-3.75 (m, 2H), 3.85 (s, 4H)
MS (FAB) m/z : MH+ 273
1,4-Dioxaspiro [4.4] non-6-ylmethyl 2,2-dimethyl 
propanoate (68g)
(68g)
OH
(66)
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A solution of the alcohol (66) (2.00 g, 12.7 mmol) 
and dry ether (25 ml) was cooled to 0° whereupon 
nbutyllithium (8.5 ml, 13.5 mmol) was added slowly, 
dropwise. During this addition a precipitate of lithium 
alkoxide appeared. After 1 hour at O0 a solution of 
distilled pivaloyl chloride (3.07 g, 12.7 mmol) in dry 
ether (10 ml) was added dropwise, the cooling bath was 
then removed and the reaction left at room temperature 
for a further 3 hours. The mixture was then poured 
carefully into iced water (75 ml) and the ether layer 
separated. The remaining aqueous layer was extracted 
with ether (3 x 25 ml) and the combined organics were 
washed with water (2 x 20 ml), dried (MgSO^) and 
concentrated. The crude product appeared as a clear 
colourless liquid (3.01 g, 98%) and was virtually pure 
(1H NMR showed >98% purity) and so no further 
purification was necessary.
IR (Liquid Film): 2950, 2860, 1720 (C=0 str), 1280,
1150 v strong
XH NMR (CDC13) : 1.2 (s, 9H), 1.35-2.5 (m, 7H),
3.80-4.2 (m, 2H), 3.85 (s, 4H)
MS (FAB) m/z : MH+ 243
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1,4-Dioxaspiro [4.4] non-6-ylmethyl benzoate (68h)
I I I °X° ►  X v ^ ' o c o c 6h 5OH
(66) (68h)
A solution of alcohol (66) (3.00 g, 19.0 mmol) and 
dry ether (30 ml) was cooled to O and butyllithium 
(12.5 ml, 20.0 mmol) was added slowly whereupon a 
precipitate of lithium alkoxide emerged. After 1 hour at 
0° a solution of benzoyl chloride (2.67 g, 19.0 mmol) in 
dry ether (10 ml) was added, the cooling bath was removed 
and stirring continued for 4 hours. The reaction mixture 
was then poured into iced water (80 ml) and the ether 
separated off. The aqueous phase was extracted with 
ether (3 x 25 ml) and the combined organics were washed 
with water (2 x 25 ml), dried (MgS04) and concentrated to 
yield crude (68h) as an orange liquid (5.22 g) which was 
purified by column chromatography (85/15; petrol/ethyl 
acetate + 2% Et3N) to produce a clear colourless liquid 
(4.78 g, 96%).
FT-IR : 2983, 2930, 1718 (C=0 str v strong),
1275 v strong, 1117, 714
NMR (CDC13) : 1.50-2.11 (m, 6H), 2.48 (quin, 1H)
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3.90 (s , 4H), 4.35 (m, 2H), 7.50-8.05 (m, 5H)
MS (FAB) m/z s MH+ 262
Microanalysis found: C, 68.53? H, 6.94? 0, 24.53 
C15H18°4 re^u -^res s c • 68.69? H, 6.92? O, 24.40
6-Methoxymethyl-l,4-dioxaspiro [4.4] non-8-ene (69)
° °/ S ^ 0 C H 3
(69)
A. Employing Br2 and NaOH
To a vigorously stirred mixture of (68a) (20.0 g, 
0.12 mol) in ethylene glycol (100 ml) was added bromine 
(18.5 g, 0.12 mol). Initially 0.5 ml of bromine was 
added and the mixture was heated to 50° until the 
solution began to decolourize whereupon it was cooled to 
below 20°. The remaining bromine was then added at such 
a rate that the mixture maintained a straw yellow colour. 
A further 30 minutes after bromine addition was complete 
the mixture was carefully poured into a vigorously 
stirring suspension of Na2C03 (29.8 g) in petrol 
(100 ml). After stirring for 1 hour, water (100 ml) was 
added and the organic layer separated. The aqueous layer
-156-
was extracted with ether (6 x 80 ml) and the combined 
organic fractions were dried (MgSO^) and concentrated to 
yield the crude bromide intermediate as a clear, light 
green liquid (27.8 g) which was used without further 
purification.
This bromide was immediately dissolved in dry ethanol 
(150 ml) and NaOH (10 g) was added and the mixture was 
refluxed with the exclusion of water for 14 hours. After 
cooling to room temperature the mixture was poured into 
water (500 ml) and extracted with dichloromethane (6 x 
100 ml). The combined dichloromethane layers were dried 
(MgS04) and concentrated to produce the crude alkene (69) 
which was most conveniently used without further 
purification in the next stage of the reaction pathway.
A portion of this sample (1.00 g) was purified by column 
chromatography (80/20? petrol/ethyl acetate + 2% Et3N) to 
yield pure (69) as a clear colourless liquid (810 mg,
63%) .
2. Employing Pyridinium Hydrobromide Perbromide and
Anhydrous Sodium Methoxide
A solution of methyl ether (68a) (500 mg, 2.91 
mmol) and dry THF (12 ml) was cooled to —78° (dry ice/ 
acetone) and pyridinium hydrobromide perbromide (1.02 g, 
3.20 mmol) was added in one portion. Stirring was 
continued until starch-iodide paper showed a negative 
result. Pyridine (250 mg, 3.20 mmol) was added with
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vigorous stirring and after a further 10 minutes the 
mixture was poured into 10% (aq) Na2C03 solution (10 ml) 
and subsequently extracted with dichloromethane (4 x 10 
ml). The combined organics were washed with water (2 x 
20 ml), dried (MgSO^) and concentrated to give the crude 
product as a clear, dark red liquid (840 mg) and this was 
used immediately without further purification.
To a suspension of NaOMe (anhy) (490 mg, 9.02 mmol) 
in dry DMSO (8 ml) at >20° was added a solution of the 
bromide crude product (840 mg) in dry DMSO (2 ml). After 
4 hours iced water (20 ml) was added and the solution 
saturated with NaCl and subsequently extracted with 
petrol (8 x 15 ml). The petrol layers were washed with 
water (2 x 30 ml), dried (MgS04) and concentrated which 
left the crude alkene (69) as a light orange liquid (360 
mg) which could be purified by column chromatography 
(80/20? petrol/ethyl acetate + 2% Et^N). This gave pure 
(69) as a clear, colourless liquid (280 mg, 57%).
3. Employing Phenyltrimethylammonium Tribromide and
Anhydrous Sodium Methoxide
To a solution of (68a) (500 mg, 2.91 mmol) in dry 
THF (12 ml) at 0° was added in one batch phenyltrimethyl­
ammonium tribromide (1.15 g, 3.06 mmol). Following two 
hours with occasional stirring the mixture was poured 
into a solution of saturated sodium bicarbonate (12 ml)/ 
0.1 N sodium thiosulphate (12 ml) and extracted with
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ether (4 x 20 ml). The combined ether portions were 
washed with water (3 x 25 ml), brine (25 ml), dried 
(Na2S04) and concentrated to produce the crude bromide 
intermediate as a clear, orange liquid (940 mg) which 
again was used without further purification.
To a suspension of anhydrous NaOMe (600 mg, 11.1 
mmol) in dry DMSO (8 ml) at <20° was added the crude 
bromide (940 mg) as a solution in dry DMSO (2 ml). 
Following 4 hours stirring iced water (20 ml) was added 
and the solution saturated with NaCl. Petrol (8 x 15 ml) 
was used to extract the crude product and the combined 
organics were washed with water (2 x 30 ml), dried 
(MgS04) and concentrated. The clear, pale green, crude 
alkene was purified by column chromatography (80/20? 
petrol/ethyl acetate + 2% Et3N) yielding pure (69) as a 
clear colourless liquid (270 mg, 55%)
Analysis of Pure (69)
IR (Liquid film): 1650 (C=C str)
XH NMR (CDC13) : 2.16 (m, 1H), 2.56 (m, 2H), 3.37-3.58
(m, 2H), 3.37 (s, 3H), 3.96 (m, 4H), 5.67 (m, 1H olefin)
6.06 (m, 1H olefin)
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1,4-Dioxaspiro [4.4] non-8-ene-6-ylmethyl-2,2- 
dimethylpropanoate from 68g
(68g)
OCOC(CH3)3
To a vigorously stirred mixture of ester (68g) (1.00 
g, 4.1 mmol) in ethylene glycol (20 ml) was added an 
initial amount of bromine (0.05 ml). The mix was heated 
to 50° and left until decolourization was initiated 
whereupon the reaction was cooled to <20° and the 
remainder of the bromine was added at a rate which 
maintained a straw yellow colour in the reaction pot. 
After 30 minutes this mixture was slowly poured into a 
suspension of Na2C0 3 (1.1 g) in petrol (10 ml) and then 
allowed to stir for a further 1 hour. Water (25 ml) was 
then added and the organic phase separated. The aqueous 
portion was extracted with dichloromethane (6 x 15 ml) 
and the combined organics were washed with water (2 x 15 
ml), dried (MgSO^) and concentrated to yield the crude 
bromide intermediate as a light amber liquid (990 mg, 3.1 
mmol).
To ^BuOK (350 mg, 3.1 mmol) and dry DMSO (8 ml) was 
added a solution of the synthesized bromide intermediate
-160-
(990 mg, 3.1 mmol) in dry DMSO (4 ml). After 14 hours 
the mixture was poured into iced water (40 ml) and 
extracted with petrol (8 x 15 ml). The organic portions 
were washed with water (2 x 30 ml), dried (MgS04) and 
concentrated to give the crude material as a clear, pale 
green liquid (410 mg). This product was used without 
purification for the subsequent ketal deprotection 
reaction.
2-oxocyclopent-3-enylmethyl 2,2-dimethylpropanoate
To a slurry of coarse silica (1.1 g) and 
dichloromethane (15 ml) was added 10% (aq) oxalic acid 
(0.11 ml) and the mixture was stirred for 15 minutes 
after which time a solution of the alkene (410 mg, 1.8 
mmol) in DCM (3 ml) was added in a couple of portions. 
After 1 hour NaHC03 (40 mg) was added and the reaction 
stirred for a further 20 minutes. The reaction was then 
filtered and the filter cake washed thoroughly with DCM 
(20 ml). The filtrate was dried (MgSO^) and concentrated
-161-
O
0C0C(CH3 )3 >
to yield a crude product which was purified by column 
chromatography (75/25; petrol/ethyl acetate) to isolate 
pure unsaturated ketone as a clear, colourless liquid (42 
mg, 12%).
IR (Liquid film): 1680-1740 (C=Ostr)
XH NMR (CDC13) : 1.0-1.30 (m, 9H), 2.33-2.8 (m, 3H),
4.15-4.30 (d, 2H), 6.1 (m, 1H olefin), 7.60 (m, 1H
olefin)
MS (El) m/z : MH+ 197
5-Methoxymethylcyclopent-2-enone
och3
(65)(69)
To a slurry of coarse silica (26.4 g) and 
dichloromethane (250 ml) was added 10% (aq) oxalic acid 
(2.7 g) and the mixture was stirred for 15 minutes after 
which time a solution of the alkene (69) (10.0 g, 59 
mmol) in DCM (45 ml) was added in a couple of portions. 
After 1 hour NaHC03 (1.1 g) was added and the reaction 
stirred for a further 20 minutes. The reaction was then
-162-
filtered and the filter cake washed thoroughly with DCM 
(100 ml). The filtrate was dried (MgS04) and 
concentrated to yield a crude product which was purified 
by column chromatography (60/40? petrol/ethyl acetate) to 
isolate pure unsaturated ketone (65) as a clear, very 
pale orange liquid (6.90g, 93%).
FT-IR : 2926, 2893, 2845, 2827,1707 (C=0 str, V  strong)
1121
XH NMR (CDC13) : 2.40-2.92 (m, 3H), 3.32 (s, 2H), 3.61
(m, 2H)# 6.19 (m, 1H olefin), 7.74 (m, 1H olefin)
MS (FAB) m/z : MH+ 127
Microanalysis found: C, 66.78? H, 8.16? O, 25.24? 
C7H10O2 requires : C, 66.64? H, 7.99? O, 25.38?
Attempted Preparation of 2-Oxocyclopent-3-enyl methanol 
from (65)
0 0
>
(65)
To the methyl ether (65) (250 mg, 1.98 mmol) was 
added in turn dry chloroform (4 ml), dry pyridine (60 mg) 
and freshly distilled trimethylsilyl iodide (622 mg, 3.11
mmol) and the mixture was heated to and kept at 60° for 
48 hours. Anhydrous methanol (2 ml) was added and the 
volatiles removed to yield a crude product which by TLC 
and proton NMR analysis was shown to be a complex mixture 
of compounds.
Attempted Preparation of 5-Bromoethylcyclopent-2- 
enone from (65)
CHoBr•OCH
(65)
To the methyl ether (65) (500 mg, 3.9 mmol) in DCM 
(10 ml) was added dropwise 8-bromocatecholborane (0.2 M 
in DCM) (19.5 ml, 3.9 mmol) and the reaction was left for 
14 hours. Water (15 ml) was added and the reaction left 
for a further 30 minutes after which time it was diluted 
with DCM (100 ml) and the organic layer separated. The 
DCM phase was washed with 10% (aq) NaOH (2 x 30 ml), 
brine (30 ml), dried (MgS04) and concentrated to yield a 
product which by TLC and proton NMR analysis was 
confirmed as recovered starting material only.
-164-
5-Methoxymethy1cyclopent-2-enol (36)
0 OH
(65) (36)
A. LiAlH. reduction4
To a slurry of LiAlH^ (455 mg, 12mmol) in dry 
ether (20 ml) at -20° (dry ice/carbon tetrachloride) was 
added slowly, dropwise, a solution of (65) (2.00 g, 16 
mmol) in dry ether (15 ml). After 2 hours 15% (aq) NaOH 
saturated with Na2S04 (4.2 ml) was cautiously added and 
the resultant mixture was filtered, the filter cake being 
thoroughly washed with ether (50 ml). The filtrate was 
dried (MgSC>4) and concentrated to yield crude (36) as a 
clear, orange mixture of isomers (1.52 g). Column 
chromatography (97/3; DCM/methanol) permitted separation 
of the two isomers and yielded the desired 6-alcohol as a 
clear colourless liquid (610 mg, 30%) with a by-product, 
saturated alcohol (15%).
B. Diisobutylaluminium hydride reduction
To a solution of ketone (65) (1.00 g, 7.9 mmol)
and dry toluene (15 ml) at -78° (dry ice/acetone) was
added slowly, dropwise, DIBAL (1.0 M in hexanes) (15.9
-165-
ml, 15.9 mmol) and the reaction kept at -78° for 2 hours. 
Methanol (10 ml) was carefully added and the mixture 
allowed to warm to room temperature whereupon water 
(2 ml) was added and the gelatinous mixture filtered 
through hyflo filter aid. The filter cake was washed 
with hot ether (4 x 30 ml) and the filtrate was 
concentrated to yield crude (36) which was purified by 
column chromatography (97/3; DCM/methanol) to isolate the 
desired 6-alcohol (658 mg, 65%) and the oC -alcohol (132 
mg, 13%) as clear, colourless liquids.
C. NaBH4/CeCl3 reduction
To a mix of the ketone (65) (1.72 g, 13.4 mmol) 
and CeCl3 (0.4 M in methanol) (35 ml, 14 mmol) at 0°
NaBH4 was added portionwise, slowly, so as to keep the 
reaction temperature below 5°. After 1 hour water (10 
ml) was added and the reaction carefully concentrated to 
approximately % its volume. A further 100 ml water was 
added and the aqueous mixture extracted with ether (8 x 
30 ml). The combined organic fractions were washed with 
brine (50 ml), dried (MgSO^) and concentrated. The crude 
mixture of alcohol isomers was purified by column 
chromatography (97/3; DCM/methanol) to yield the 6- 
alcohol (961 mg, 56%) and the oL -alcohol (410 mg, 24%) 
as clear, colourless liquids.
IR (Liquid film): 3250-3600 (br, O-H str),1670 (C=C str)
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XH NMR-360 MHz (CDC13) :
6-Isomer : 2.10-2.42 (m, 2H), 2.52 (m, 1H), 3.39 (in, 
3H), 3.58 (m, 2H), 4.83 (d, 1H), 5.84 (m, 1H, olefin) 
5.97 (m, 1H, olefin)
0^ -Isomer s 2.0 (m, 1H), 2.32 (m, 1H), 2.58 (m, 1H), 
3.35 (m, 1H), 3.40 (m, 2H), 4.65 (s, 1H), 5.75 (m, 1H 
olefin), 5.88 (m, 1H, olefin)
MS (FAB) m/z S MH+ 129, MH+-31 98
cis-N-4-Methoxymethylcyclopent-2-eny1trichloro- 
acetamide (78)
(78)(3HO
To sodium hydride (48 mg, 1.2 mmol) was added petrol 
(5 ml) and the oil removed with a pipette. The hydride 
was then suspended in dry ether (8 ml). To this was 
added, dropwise, a solution of alcohol (36) (1.50 g, 12 
mmol) in dry ether (5 ml). Stirring was continued for 15 
minutes after completion of hydrogen evolution whereupon 
the mixture was cooled to 0°. A separate flask was 
charged with trichloroacetonitrile (1.73 g, 12 mmol) and
-167-
dry ether (8 ml) and cooled to 0°. The alkoxide solution 
was then slowly transferred via a syringe into the 
trichloroacetonitrile mixture and this was left for 2 
hours whereupon the solvents were removed under reduced 
pressure. A solution of petrol (25 ml) containing 
methanol (0 .1%) was added and the mixture shaken 
vigorously for 1 minute. The resultant solution was 
filtered by gravity and the process was repeated twice 
more. The combined filtrates were concentrated to yield 
the crude intermediate imidate as a clear, light green 
liquid (3.04 g).
IR (Liquid film): 3500-3000 (No OH str), 3340 (NH str),
1660 (C=N str, v strong)
This crude imidate was, without purification, 
dissolved in dry toluene and refluxed with the exclusion 
of water for 6 hours. Cooling and subsequent 
concentration of the reaction mixture yielded crude (78) 
as a dark brown viscous liquid which was purified by 
column chromatography (60/40? petrol/ethyl acetate) to 
give the desired trichloroacetamide (78) as a white 
crystalline solid (2.22 g, 68%).
IR (KBr disc) : 3340 (N-H str), 2980, 2940, 2900, 2840,
1730 (C=0 str), 1530, 820 strong
XH NMR (CDC13) : 1.7 (m, 1H), 2.4 (m, 1H), 3.25-3.45 (m,
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3H), 3.30 (s, 3H), 4.80 (m, 1H), 5.7 (m, 2H olefin),
7.45, (s, br, 1H)
Microanalysis found : C, 39.85; H, 4.38; N, 5.09 
C9H12C13N02 re(S^ires s c * 39.66; H, 4.44; N, 5.14
2-Amino-4-chloro-6- (4-methoxymethylcyclopent-2-enyl) amino 
pyrimidine (83)
ch3c>>  NHC(0)CC13
(78)
To the trichloroacetamide (78) (1.00 g, 3.7 mmol) was 
added ethanol (25 ml) and 2N HC1 (25 ml) and the mixture 
refluxed for 54 hours. After solvent removal under 
reduced pressure n-butanol (45 ml), 2-amino-4,6-dichloro- 
pyrimidine (2.00 g, 12 mmol) and diisopropylethylamine 
(15 ml) were added and the mixture refluxed under 
nitrogen for 36 hours. Following cooling the mix was 
poured into water (60 ml) and the product extracted with 
DCM (5 x 150 ml). The combined organics were dried 
(MgS04) and concentrated to produce an orange syrup which 
was purified by column chromatography (50/50; petrol/ 
ethyl acetate) to yield (83) as an off-white solid
Cl
(83)
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(770 mg, 82%).
m.p 106-108O
IR (KBr disc) s 3100-3450 (NH2 str),
1630/1580 (C=C, C=N str)
XH HHR (CDC13) s 1.35 (m, 1H), 2.60 (m, 1H)., 3.20-3.50 
(m, 3H), 3.30 (s, 3H), 4.85 (s, br, 2H), 5.00 (s, 1H)
5.25-5.60 (m, 2H), 5.65-5.85 (m, 2H olefin)
5-Amino-2-chloro-6-(4-methoxymethylcyclopent-2-enyl) 
aminopyrimidine (79)
To the trichloroacetamide (78) (1.00 g, 3.7 mmol) was 
added ethanol (25 ml) and 2N HC1 (25 ml) and the mixture 
refluxed for 54 hours. After solvent removal under 
reduced pressure n-butanol (45 ml), 5-amino-4,6-dichloro- 
pyriroidine (2.00 g, 12 mmol) and diisopropylethylamine 
(15 ml) were added and the mixture refluxed under 
nitrogen for 24 hours. Following cooling the mix was 
poured into water (60 ml) and the product extracted with
Cl
(78) (79)
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DCM (5 x 150 ml). The combined organics were dried 
(MgS04) and concentrated to produce crude (79) as a 
yellow syrup which was purified by column chromatography 
(50/50? petrol/ethyl acetate) to yield (79) as a pale 
yellow solid. This product was further purified by 
recrystallization (petrol/ethyl acetate) to yield pure 
(79) as white needles (570 mg, 61%).
m.p. : 114-116°
IR (KBr disc) : 3000-3550 (NH2 str), 2980, 2940, 2880,
1630/1590 (C=C, C=N str), 1125 v strong
XH NMR (CDC13) : 1.35 (m, 1H), 2.60 (m, 1H), 3.20-3.50
(m, 3H), 3.30 (s, 3H), 4.85 (s, br, 2H), 5.00 (s, 1H)
5.25-5.60 (m, 2H) , 5.65-5.85 (m, 2H olefin)
MS (El) m/z : M+ , 254, M+ (37C1), 256,
MH+ (-OCH3), 224 
H.R.M.S. found : 254.0944
H.R.M.S. requires : 254.0934 (for C^jH^N^ClO)
6-Chloro-9-^-methoxymethylcyclopent-2-eny^-9H- 
purine (80)
Cl
H N
(79)
Cl
(80)-171-
To the pyrimidine (79) (400 mg, 1.57 mmol) was added 
freshly distilled triethylorthoformate (9.5 ml) and c.HCl 
(0.4 ml) and the mixture was stirred at room temperature 
for 24 hours. The volatiles were removed and the residue 
stirred in 0.5 N HC1 (15 ml) for 1 hour after which the 
reaction mix was taken to pH 8 by the careful addition of 
IN NaOH. The mixture was again concentrated this time to 
yield crude (80) as an orange-brown solid (378 mg).
Column chromatography (ethyl acetate) yielded (80) as an 
off-white crystalline solid (332 mg, 80%).
m.p. s 88-90°
IR (KBr disc) : 3100, 3060, 2980, 2920,1630/1590 (C=C,
C=N str) 1200, 640
NMR (CDC13) : 1.7 (m, 1H), 2.80 (m, 1H), 3.05
(m,1H), 3.25-3.45 (m, 3H), 3.25 (s, 3H), 5.65 (m, 1H), 
5.78 (m, 1H, olefin), 6.15 (m, 1H, olefin),
8.25 (s, 1H), 8.64 (s, 1H)
MS (El) m/z : M+ , 264, M+ (37C1), 266
H.R.M.S. found : 264.0773
H.R.M.S. requires : 264.0777 (for C12H13N4C10)
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7-Chloro-3-(4-methoxyniethylcyclopent-2-enyl)-8-azapurine (84)
Pyrimidine (79) (100 mg, 0.39 mmol) was dissolved in
To this was added a cold solution of sodium nitrite 
(32 mg, 0.47 mmol). After 2 hours TLC showed complete 
disappearance of the starting pyrimidine and the reaction 
mix was poured into water (8 ml). This aqueous phase was
extracted with DCM ( 4 x 5 ml) and the combined organics
were washed with 2N NaOH (2 x 5 ml), water (5 ml), brine 
(5 ml), dried (MgS04) and concentrated to give a crude 
light brown crystalline solid. Recrysallization from 
ethyl acetate/petrol yielded (84) as an off-white 
crystalline solid (76 mg, 73%).
m.p. : 71-73°
IR (KBr disc) : 1630/1590 (C=C, C=N str)
NMR (CDC13) : 2.1 (m, 1H), 2.8 (m, 1H), 3.12 (m, 1H)
3.31 (s, 3H), 3.45 (m, 2H), 5.92 (m, 1H, olefin),
6.08 (m, 1H), 6.2 (m, 1H, olefin), 8.85 (s, 1H)
Cl n
(79) (84)
acetic acid (1.5 ml) and water (2.0 ml) and cooled to O0.
-173-
6-Hydroxy-9-(4-methoxymethylcyclopent-2-enyl)-9H-
purine (81)
The chloropurine (80) (100 mg, 0.378 mmol) was 
refluxed under nitrogen in 0.3N NaOH (5 ml) for 4 hours. 
The mixture was then neutralised with 0.5N HC1 and 
concentrated to yield crude (81) as a dark brown liquid 
which was purified by column chromatography (90/10; 
DCM/methanol) to give (81) as an off-white solid (61 mg, 
66%).
m.p. : 60-62°
IR (KBr disc) : 3100-3500 (O-H str), 1710 (C=0 str),
1570 (C=C/C=N str)
NMR (CDC13) : 1.7 (m, 1H), 2.85 (m, 1H), 3.05 (m,
1H), 3.15-3.50 (m, 2H), 3.25 (s, 3H), 6.0 (m, 1H olefin), 
6.15 (m, 1H olefin), 8.15 (s, 1H), 8.50 (s, 1H),
12.8 (s, br, 1H)
MS (El) m/z s MH+ 247
H.R.M.S. found s 246.1110
H.R.M.S. requires s 246.1117 (for C12H14N4°2^
Cl OH
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4-Methoxymethylcyclopent-5-enylmethoxyformate (75)
CH30 CH3O .co2ch3
>
HO (75)
(36)
A mixture of the alcohol (36) (1.00 g, 7.9 mmol), 
trimethyl orthoacetate (15 ml) and propionic acid (0.1 
ml) was refluxed under a positive pressure of nitrogen 
for 18 hours. The solution was then concentrated to 
yield the crude ester as a light yellow liquid (1.46 g). 
Column chromatography (90/10; petrol/ethyl acetate) 
yielded the pure ester (75) as a clear, colourless liquid 
(1.10 g, 76%).
FT-IR : 2990, 2928, 2876, 2827, 1756 (C=0 str), 1244,
1190
XH NMR (CDC13) s 1.60-2.60 (m, 4H), 2.05 (d, 2H), 3.25- 
3.45 (m, 2H), 3.35 (s, 3H), 3.65 (s, 3H), 5.75 (s, 2H 
olefin)
MS (FAB) m/z : MH+ 185
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Methyl-2-(4-methoxymethylcyclopent-2-enyl)-3-methoxy
propenoate (76)
OCH3
CH
(76)(75)
To sodium hydride (46 ng, 1.15 mmol) was added petrol 
(2 ml) and the oil removed with a pipette. Dry THF 
(5 ml), ethanol (4 mg) and the starting ester (75) (200 
mg, 1.09 mmol) were added quickly followed by ethyl 
formate (81 mg, 1.09 mmol). The reaction was left 
stirring under nitrogen for 12 hours after which time 
methyl iodide (200 mg, 1.40 mmol) was added. After 4 
hours the mixture was concentrated and the residue 
adsorped onto silica, which was immediately purified by 
column chromatography (50/50? petrol ethyl acetate) to 
yield two products. The minor product proved to be the 
desired di-ene (76) (36 mg, 0.16 mmol).
IR (Liquid film): 3400-3080 (OH str), 1735 (C=0 str)
MS (El) m/z : MH+ 226
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N ,N-Dimethyl-(4-methoxymethylcyclopent-2-enyl) acetamide
To the alcohol (36) (1.00 g, 7.09 mmol) was added 
dimethylacetamide dimethylacetal (5.26 g, 39.5 mmol) and 
o-xylene and this mixture was refluxed under nitrogen for 
48 hours. The solution was then concentrated to yield 
the crude amide as an amber liquid (1.64 g) which was 
purified by column chromatography (90/10; ethyl acetate/ 
petrol). The pure amide (74) appeared as a clear, pale 
yellow liquid (1.15 g, 74%).
FT-IR : 2920, 2893, 2870, 2827,1649 (C=0 str), 1396,
1111, 741
XH NMR (CDC13) : 1.60 (m, 1H), 1.90 (m, 1H), 2.35 (m,
3H), 2.95 (s, 3H), 3.00 (s, 3H), 3.25 (m, 3H), 3.35 (s, 
3H), 5.80 (m, 2H olefin)
MS (FAB) m/Z 2 MH+ 198
O
(i)
(74)OH
(36)
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2-Bromocyclopentanone
O 0
To a refluxing mixture of cyclopentanone (1.0 g, 11.9 
mmol), chloroform (10 ml) and ethyl acetate (10 ml) was 
added over 2 hours, powdered cupric bromide (5.3 g, 23.8 
mmol), allowing the green colouration produced to subside 
before the next addition. After a further 1% hours the 
reaction was cooled to room temperature and filtered with 
the filter cake being washed with chloroform (10 ml).
The filtrate was concentrated to give the crude alpha- 
bromoketone as a dark brown oil. This crude mixture was 
dissolved in ether (40 ml) and the organic layer washed 
with water (15 ml), 5% sodium bicarbonate (2 x 15 ml) and 
brine (15 ml), dried (Na2S04) and concentrated to yield 
the crude bromoketone as a pale yellow liquid (1.23 g, 
63%). This bromoketone was sufficiently pure for use in 
the next reaction of the proposed scheme 26.
IR (Liquid film): 1690 (C=0 str)
1H NMR (CDC13) : 2.0-2.55 (m, 6H), 4.15 (m, 1H)
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2-Phenylthiocyclopentanone (70)
O O
Br C6H5
(70)
To dry ethanol (10 ml) was added metallic sodium (140 
mg, 6.2 mmol) and the mixture stirred until complete 
disappearance of any solid. A solution of thiophenol 
(680 mg, 6.2 mmol) and dry ethanol (5 ml) was added 
dropwise. After \ hour a solution of the bromoketone 
(1.01 g, 6.2 mmol) in dry ethanol (5 ml) was added slowly 
and the resultant mixture was left for 8 hours. The 
reaction mixture was poured into iced water (120 ml) and 
the aqueous phase extracted with ether (3 x 30 ml). The 
combined organics were washed with water (25 ml), 2N NaOH 
(25 ml), brine (25 ml), dried (MgSO^) and concentrated to 
produce crude (70) as a yellow oil (970 mg). Column 
chromatography (70/30? petrol/ethyl acetate) yielded pure 
(70) as a clear, colourless, pungent oil (870 mg, 73%).
IR (Liquid film): 3020-3080 (C-H str), 1690 (C=0 str)
1580/1500 (C=C str)
XH NMR (CDC13) : 1.85-2.50 (m, 6H), 3.50 (m, 1H), 7.15
(m, 5H)
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2-Phenylsulphinylcyclopentanone (71)
O O
(70) (71)
To a mixture of sulphide (70) 10.6 g, 55.3 mmol) and 
methanol (125 ml) at 0° was added, over 20 minutes, a 
suspension of NaIC>4 (11.83 g, 55.3 mmol) in water 
(60 ml). After 48 hours at room temperature the reaction 
mixture was filtered and the filter cake washed with 
methanol (40 ml). The filtrate was concentrated and the 
residue dissolved in DCM (50 ml) which was then washed 
with water (2 x 25 ml). The combined aqueous portions 
were extracted with DCM (3 x 20 ml) and all the organic 
phases were dried (MgSO^) and concentrated to give the 
crude sulphoxide as a deep red liquid (10.23 g). Column 
chromatography (90/10? ethyl acetate/petrol) yielded the 
sulphoxide (71) as a pale yellow solid which could be 
further purified by recrystalization (ethyl acetate/ 
petrol) to give a white solid (9.32 g, 81%).
IR (KBr Disc) : 3000-3080 (C-H str), 1700 (C=0
str), 1590/1490 (OC str)
XH NMR (CDC13): 1.75-2.45 (m, 6H), 3.25 (m, 1H), 7.4 (s,
5H)
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Attempted Preparation of 2-Benzyloxymethyl-5-Phenylsulph- 
inylcyclopentanone (72)
(71)
C6H5CH2OCH2
(72)
A flame dried flask was charged with diisopropylamine 
(320 mg, 3.17 mmol) and dry THF (3 ml) and the solution 
was cooled to -20° (dry ice/CCl4). n-Butyllithium (2.0 
ml, 3.17 mmol) was added dropwise and after a further 10 
minutes a solution of the sulphoxide (71) (300 mg,
1.44 mmol), HMPA (260 mg, 1.44 mmol) and dry THF (3 ml) 
was added, slowly. After stirring for 30 minutes a 
mixture of the benzyloxymethyl chloride (240 mg, 1.50 
mmol) in dry THF (2 ml) was added, dropwise and the 
reaction left for 4 hours. The mix was quenched with 2N 
HCl (10 ml) and the aqueous phase extracted with DCM (3 x 
15 ml). The combined organics were dried (Na2S04 ) and 
concentrated to yield a crude product whose NMR spectral 
analysis confirmed that starting materials only had been 
recovered.
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